• 2025
  Riccardo Vernuccio, Alejandro Martínez León, Chetan Poojari, Julian Buchrieser, Christopher Selverian, Yakin Jaleta, Annalisa Meola, Florence Guivel-Benhassine, Françoise Porrot, Ahmed Haouz, Maelenn Chevreuil, Bertrand Raynal, Jason Mercer, Etienne Simon-Loriere, Kartik Chandran, Olivier Schwartz, Jochen Hub, Pablo Guardado-Calvo, Structural insights into tecovirimat antiviral activity and poxvirus resistance, Nature Microbiology, In press, ⟨10.1038/s41564-025-01936-6⟩.
• 2024
  Serrano T, Casartelli N, Ghasemi F, Wioland H, Cuvelier F, Salles A, Moya-Nilges M, Welker L, Bernacchi S, Ruff M, Jégou A, Romet-Lemonne G, Schwartz O, Frémont S, Echard A, HIV-1 budding requires cortical actin disassembly by the oxidoreductase MICAL1., Proc Natl Acad Sci U S A 2024 Nov; 121(48): e2407835121.
• 2024
  Fourati S, Reslan A, Bourret J, Casalegno JS, Rahou Y, Chollet L, Pillet S, Tremeaux P, Dossou NC, Gault E, Salmona M, Imbert-Marcille BM, Mirand A, Larrat S, Moisan A, Marot S, Schnuriger A, Veyrenche N, Engelmann I, Handala L, Henry A, Stephan V, Brichler S, Avettand-Fenoel V, Zemali N, Lefeuvre C, Pronier C, Deroche L, Jaffar-Bandjee MC, Mouna L, Francois C, Regueme A, Hartard C, Rogez S, Gallais F, Ly A, Rodriguez C, Dos Santos G, Simon-Loriere E, Schwartz O, Buchrieser J, Pawlotsky JM, Lemoine F, Audureau E, Rameix-Welti MA, Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world study., Lancet Infect Dis 2024 Oct; (): .
• 2024
  Jeger-Madiot R, Planas D, Staropoli I, Debarnot H, Kervevan J, Mary H, Collina C, Fonseca BF, Robinot R, Gellenoncourt S, Schwartz O, Ewart L, Bscheider M, Gobaa S, Chakrabarti LA, Modeling memory B cell responses in a lymphoid organ-chip to evaluate mRNA vaccine boosting., J Exp Med 2024 Oct; 221(10): .
• 2024
  Inizan C, Courtot A, Sturmach C, Griffon AF, Biron A, Bruel T, Enouf V, Demaneuf T, Munier S, Schwartz O, Gourinat AC, Médevielle G, Jouan M, van der Werf S, Madec Y, Albert-Dunais V, Dupont-Rouzeyrol M, Levels and functionality of Pacific Islanders’ hybrid humoral immune response to BNT162b2 vaccination and delta/omicron infection: A cohort study in New Caledonia., PLoS Med 2024 Sep; 21(9): e1004397.
• 2024
  Planchais C, Fernández I, Chalopin B, Bruel T, Rosenbaum P, Beretta M, Dimitrov JD, Conquet L, Donati F, Prot M, Porrot F, Planas D, Staropoli I, Guivel-Benhassine F, Baquero E, van der Werf S, Haouz A, Simon-Lorière E, Montagutelli X, Maillère B, Rey FA, Guardado-Calvo P, Nozach H, Schwartz O, Mouquet H, Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2., iScience 2024 Jul; 27(7): 110354.
• 2024
  Fernández I, Saunders N, Duquerroy S, Bolland WH, Arbabian A, Baquero E, Blanc C, Lafaye P, Haouz A, Buchrieser J, Schwartz O, Rey FA, Structural basis of TMPRSS2 zymogen activation and recognition by the HKU1 seasonal coronavirus., Cell 2024 Jun; (): .
• 2024
  Saunders N, Monel B, Cayet N, Archetti L, Moreno H, Jeanne A, Marguier A, Buchrieser J, Wai T, Schwartz O, Fréchin M, Dynamic label-free analysis of SARS-CoV-2 infection reveals virus-induced subcellular remodeling., Nat Commun 2024 Jun; 15(1): 4996.
• 2024
  Brunet J, Choucha Z, Gransagne M, Tabbal H, Ku M-W, Buchrieser J, Fernandes P, Batalie D, Lopez J, Ma L, Dufour E, Simon E, Hardy D, Petres S, Guinet F, Strick-Marchand H, Monot M, Charneau P, Majlessi L, Duprex WP, Gerke C, Martin A, Escriou N, A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model., J Virol 2024 Apr; (): e0169323.
• 2024
  Jungbauer-Groznica M, Wiese K, Fischer I, Markus J, Chang TH, Gösler I, Kowalski H, Blaas D, Real-Hohn A, Aichivirus A1 replicates in human intestinal epithelium and bronchial tissue: Lung-gut axis?, Virus Res 2024 Apr; 342(): 199338.
• 2024
  Planas D, Staropoli I, Michel V, Lemoine F, Donati F, Prot M, Porrot F, Guivel-Benhassine F, Jeyarajah B, Brisebarre A, Dehan O, Avon L, Bolland WH, Hubert M, Buchrieser J, Vanhoucke T, Rosenbaum P, Veyer D, Péré H, Lina B, Trouillet-Assant S, Hocqueloux L, Prazuck T, Simon-Loriere E, Schwartz O, Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion., Nat Commun 2024 Mar; 15(1): 2254.
• 2024
  Benotmane I, Jungbauer-Groznica M, Staropoli I, Planas D, Dehan O, Brisebarre A, Simon-Loriere E, Fafi-Kremer S, Schwartz O, Bruel T, Caillard S, In Vitro and In Vivo Neutralizing Efficacy of Monoclonal Antibodies Against Sars-Cov-2 Variants in Kidney Transplant Recipients., Transpl Int 2024 ; 37(): 13272.
• 2024
  Planas D, Staropoli I, Planchais C, Yab E, Jeyarajah B, Rahou Y, Prot M, Guivel-Benhassine F, Lemoine F, Enouf V, Simon-Loriere E, Mouquet H, Rameix-Welti MA, Schwartz O, Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP3.3 From Approved Monoclonal Antibodies., Pathog Immun 2024 ; 10(1): 1-11.
• 2023
  Bolland W, Michel V, Planas D, Hubert M, Staropoli I, Guivel-Benhassine F, Porrot F, N'Debi M, Rodriguez C, Fourati S, Prot M, Planchais C, Hocqueloux L, Simon-Lorière E, Mouquet H, Prazuck T, Pawlotsky J-M, Bruel T, Schwartz O, Buchrieser J, High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1., J Virol 2023 Dec; (): e0135123.
• 2023
  Saunders N, Fernandez I, Planchais C, Michel V, Rajah MM, Baquero Salazar E, Postal J, Porrot F, Guivel-Benhassine F, Blanc C, Chauveau-Le Friec G, Martin A, Grzelak L, Oktavia RM, Meola A, Ahouzi O, Hoover-Watson H, Prot M, Delaune D, Cornelissen M, Deijs M, Meriaux V, Mouquet H, Simon-Lorière E, van der Hoek L, Lafaye P, Rey F, Buchrieser J, Schwartz O, TMPRSS2 is a functional receptor for human coronavirus HKU1., Nature 2023 Oct; (): .
• 2023
  Yann Aquino, Aurélie Bisiaux, Zhi Li, Mary O'Neill, Javier Mendoza-Revilla, Sarah Hélène Merkling, Gaspard Kerner, Milena Hasan, Valentina Libri, Vincent Bondet, Nikaïa Smith, Camille de Cevins, Mickaël Ménager, Francesca Luca, Roger Pique-Regi, Giovanna Barba-Spaeth, Stefano Pietropaoli, Olivier Schwartz, Geert Leroux-Roels, Cheuk-Kwong Lee, Kathy Leung, Joseph Wu, Malik Peiris, Roberto Bruzzone, Laurent Abel, Jean-Laurent Casanova, Sophie Valkenburg, Darragh Duffy, Etienne Patin, Maxime Rotival, Lluis Quintana-Murci, Dissecting human population variation in single-cell responses to SARS-CoV-2, Nature, 2023, 53 (8), pp.e2250307. ⟨10.1038/s41586-023-06422-9⟩.
• 2023
  Hubert M, Guivel-Benhassine F, Bruel T, Porrot F, Planas D, Vanhomwegen J, Wiedemann A, Burrel S, Marot S, Palich R, Monsel G, Diombera H, Gallien S, Lopez-Zaragoza JL, Vindrios W, Taieb F, Fernandes-Pellerin S, Delhaye M, Laude H, Arowas L, Ungeheuer MN, Hocqueloux L, Pourcher V, Prazuck T, Marcelin AG, Lelièvre JD, Batéjat C, Lévy Y, Manuguerra JC, Schwartz O, Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals., Cell Host Microbe 2023 Jun; 31(6): 937-948.e4.
• 2023
  Woudenberg T, Pinaud L, Garcia L, Tondeur L, Pelleau S, De Thoisy A, Donnadieu F, Backovic M, Attia M, Hozé N, Duru C, Koffi AD, Castelain S, Ungeheuer MN, Fernandes Pellerin S, Planas D, Bruel T, Cauchemez S, Schwartz O, Fontanet A, White M, Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021., Euro Surveill 2023 Jun; 28(25): .
• 2023
  Real-Hohn A, Groznica M, Kontaxis G, Zhu R, Chaves OA, Vazquez L, Hinterdorfer P, Kowalski H, Blaas D, Stabilization of the Quadruplex-Forming G-Rich Sequences in the Rhinovirus Genome Inhibits Uncoating-Role of Na+ and K., Viruses 2023 Apr; 15(4): .
• 2023
  Znaidia M, de Souza-Angelo Y, Létoffé S, Staropoli I, Grzelak L, Ghigo JM, Schwartz O, Casartelli N, Exposure to Secreted Bacterial Factors Promotes HIV-1 Replication in CD4+ T Cells., Microbiol Spectr 2023 Feb; (): e0431322.
• 2023
  Planas D, Bruel T, Staropoli I, Guivel-Benhassine F, Porrot F, Maes P, Grzelak L, Prot M, Mougari S, Planchais C, Puech J, Saliba M, Sahraoui R, Fémy F, Morel N, Dufloo J, Sanjuán R, Mouquet H, André E, Hocqueloux L, Simon-Loriere E, Veyer D, Prazuck T, Péré H, Schwartz O, , Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies., Nat Commun 2023 Feb; 14(1): 824.
• 2023
  Kervevan J, Staropoli I, Slama D, Jeger-Madiot R, Donnadieu F, Planas D, Pietri MP, Loghmari-Bouchneb W, Alaba Tanah M, Robinot R, Boufassa F, White M, Salmon-Ceron D, Chakrabarti LA, Divergent adaptive immune responses define two types of long COVID., Front Immunol 2023 ; 14(): 1221961.
• 2022
  Smith N, Possémé C, Bondet V, Sugrue J, Townsend L, Charbit B, Rouilly V, Saint-André V, Dott T, Pozo AR, Yatim N, Schwartz O, Cervantes-Gonzalez M, Ghosn J, Bastard P, Casanova JL, Szwebel TA, Terrier B, Conlon N, O'Farrelly C, Cheallaigh CN, Bourke NM, Duffy D, Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity., Nat Commun 2022 Nov; 13(1): 7254.
• 2022
  Planas D, Bruel T, Staropoli I, Guivel-Benhassine F, Porrot F, Maes P, Grzelak L, Prot M, Mougari S, Planchais C, Puech J, Saliba M, Sahraoui R, Femy F, Morel N, Dufloo J, Sanjuan R, Mouquet H, Andre E, Hocqueloux L, Simon-Loriere E, Veyer D, Prazuck T, Pere H, Schwartz O, , Resistance of Omicron subvariants BA.2.75.2, BA.4.6 and BQ.1.1 to neutralizing antibodies., bioRxiv 2022 Nov; (): .
• 2022
  Bruel T, Stéfic K, Nguyen Y, Toniutti D, Staropoli I, Porrot F, Guivel-Benhassine F, Bolland WH, Planas D, Hadjadj J, Handala L, Planchais C, Prot M, Simon-Lorière E, André E, Baele G, Cuypers L, Mouthon L, Mouquet H, Buchrieser J, Sève A, Prazuck T, Maes P, Terrier B, Hocqueloux L, Schwartz O, , Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies., Cell Rep Med 2022 Nov; (): 100850.
• 2022
  Laplantine E, Chable-Bessia C, Oudin A, Swain J, Soria A, Merida P, Gourdelier M, Mestiri S, Besseghe I, Bremaud E, Neyret A, Lyonnais S, Favard C, Benaroch P, Hubert M, Schwartz O, Guerin M, Danckaert A, Del Nery E, Muriaux D, Weil R, , The FDA-approved drug Auranofin has a dual inhibitory effect on SARS-CoV-2 entry and NF-κB signaling., iScience 2022 Oct; 25(10): 105066.
• 2022
  Planas D, Staropoli I, Porot F, Guivel-Benhassine F, Handala L, Prot M, Bolland WH, Puech J, Péré H, Veyer D, Sève A, Simon-Lorière E, Bruel T, Prazuck T, Stefic K, Hocqueloux L, Schwartz O, , Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection., Med (N Y) 2022 Dec; 3(12): 838-847.e3.
• 2022
  Gellenoncourt S, Saunders N, Robinot R, Auguste L, Rajah MM, Kervevan J, Jeger-Madiot R, Staropoli I, Planchais C, Mouquet H, Buchrieser J, Schwartz O, Chakrabarti LA, , The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants., J Virol 2022 Oct; 96(19): e0130122.
• 2022
  Bruel T, Pinaud L, Tondeur L, Planas D, Staropoli I, Porrot F, Guivel-Benhassine F, Attia M, Pelleau S, Woudenberg T, Duru C, Koffi AD, Castelain S, Fernandes-Pellerin S, Jolly N, De Facci LP, Roux E, Ungeheuer MN, Van Der Werf S, White M, Schwartz O, Fontanet A, Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study., EClinicalMedicine 2022 Sep; 51(): 101576.
• 2022
  Garcez ML, Bellettini-Santos T, Schiavo GL, Calixto KV, Mina F, Medeiros EB, Zabot GC, Pereira NS, Nascimento NBD, Tomaz DB, Alexandre MCM, Kucharska E, Rico EP, Budni J, , Long-term administration of soft drink causes memory impairment and oxidative damage in adult and middle-aged rats., Exp Gerontol 2022 Sep; 166(): 111873.
• 2022
  Grzelak L, Roesch F, Vaysse A, Biton A, Legendre R, Porrot F, Commère PH, Planchais C, Mouquet H, Vignuzzi M, Bruel T, Schwartz O, , IRF8 regulates efficacy of therapeutic anti-CD20 monoclonal antibodies., Eur J Immunol 2022 Aug; (): .
• 2022
  Momboisse F, Nardi G, Colin P, Hery M, Cordeiro N, Blachier S, Schwartz O, Arenzana-Seisdedos F, Sauvonnet N, Olivo-Marin JC, Lagane B, Lagache T, Brelot A, Tracking receptor motions at the plasma membrane reveals distinct effects of ligands on CCR5 dynamics depending on its dimerization status., Elife 2022 Jul; 11(): .
• 2022
  Vabret N, Najburg V, Solovyov A, Gopal R, McClain C, Šulc P, Balan S, Rahou Y, Beauclair G, Chazal M, Varet H, Legendre R, Sismeiro O, Sanchez David RY, Chauveau L, Jouvenet N, Markowitz M, van der Werf S, Schwartz O, Tangy F, Bhardwaj N, Greenbaum BD, Komarova AV, Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1., iScience 2022 Jul; 25(7): 104599.
• 2022
  Wu Y, Mahtal N, Paillares E, Swistak L, Sagadiev S, Acharya M, Demeret C, Werf SV, Guivel-Benhassine F, Schwartz O, Petracchini S, Mettouchi A, Caramelle L, Couvineau P, Thai R, Barbe P, Keck M, Brodin P, Machelart A, Sencio V, Trottein F, Sachse M, Chicanne G, Payrastre B, Ville F, Kreis V, Popoff MR, Johannes L, Cintrat JC, Barbier J, Gillet D, Lemichez E, , C910 chemical compound inhibits the traffiking of several bacterial AB toxins with cross-protection against influenza virus., iScience 2022 Jul; 25(7): 104537.
• 2022
  Garcia L, Woudenberg T, Rosado J, Dyer AH, Donnadieu F, Planas D, Bruel T, Schwartz O, Prazuck T, Velay A, Fafi-Kremer S, Batten I, Reddy C, Connolly E, McElheron M, Kennelly SP, Bourke NM, White MT, Pelleau S, , Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination., Viruses 2022 07; 14(7): .
• 2022
  Alexandre M, Marlin R, Prague M, Coleon S, Kahlaoui N, Cardinaud S, Naninck T, Delache B, Surenaud M, Galhaut M, Dereuddre-Bosquet N, Cavarelli M, Maisonnasse P, Centlivre M, Lacabaratz C, Wiedemann A, Zurawski S, Zurawski G, Schwartz O, Sanders RW, Le Grand R, Levy Y, Thiébaut R, , Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection., Elife 2022 Jul; 11(): .
• 2022
  Bruel T, Hadjadj J, Maes P, Planas D, Seve A, Staropoli I, Guivel-Benhassine F, Porrot F, Bolland WH, Nguyen Y, Casadevall M, Charre C, Péré H, Veyer D, Prot M, Baidaliuk A, Cuypers L, Planchais C, Mouquet H, Baele G, Mouthon L, Hocqueloux L, Simon-Loriere E, André E, Terrier B, Prazuck T, Schwartz O, Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies., Nat Med 2022 Jun; 28(6): 1297-1302.
• 2022
  Grilo C, Afonso BC, Afonso F, Alexandre M, Aliácar S, Almeida A, Alonso IP, Álvares F, Alves P, Alves PC, Alves P, Amado A, Amendoeira V, Amorim F, da Silva Aparício G, Araújo R, Ascensão F, Augusto M, Bandeira V, Barbosa AM, Barbosa S, Barbosa S, Barreiro S, Barros P, Barros T, Barros F, Basto M, Bernardino J, Bicho S, Biedma LE, Borges M, Braz L, Brito JC, Brito T, Cabral JA, Calzada J, Camarinha C, Carapuço M, Cardoso P, Carmo M, Carrapato C, da Silva Carrilho M, Carvalho DFTCS, Carvalho F, Carvalho J, Castro D, Castro G, Castro J, Castro LR, Catry FX, Cerveira AM, Cid A, Clarke R, Conde C, Conde J, Costa J, Costa M, Costa P, Costa C, do Couto AP, Craveiro J, Dias M, Dias S, Duarte B, Duro V, Encarnação C, Eufrázio S, Fael A, Falé JS, Faria S, Fernandes C, Fernandes M, da Costa GF, Ferreira C, Ferreira DF, Ferreira E, Ferreira JP, Ferreira J, Ferreira D, Fonseca C, Fontes I, Fragoso R, Franco C, Freitas T, Gabriel SI, Gibb R, Gil P, Gomes CPJ, Horta P, Gomes P, Gomes V, Grilo F, Guedes A, Guilherme F, Gutiérrez I, Harper H, Herrera JM, Hipólito D, Infante S, Jesus J, Jones KE, Laborde MI, de Oliveira LL, Leitão I, Lemos R, Lima C, Linck P, Lopes H, Lopes S, López-Baucells A, Loureiro A, Loureiro F, Lourenço R, Lourenço S, Lucas P, Magalhães A, Maldonado C, Marcolin F, Marques S, Marques JT, Marques C, Marques P, Marrecas PC, Martins F, Martins R, Mascarenhas M, Mata VA, Mateus AR, Matos M, Medinas D, Mendes T, Mendes G, Mestre F, Milhinhas C, Mira A, Monarca RI, Monteiro N, Monteiro B, Monterroso P, Nakamura M, Negrões N, Nóbrega EK, Nóvoa M, Nunes M, Nunes NJ, Oliveira F, Oliveira JM, Palmeirim JM, Pargana J, Paula A, Paupério J, Pedroso NM, Pereira G, Pereira PF, Pereira J, Pereira MJR, Petrucci-Fonseca F, Pimenta M, Pinto S, Pinto N, Pires R, Pita R, Pontes C, Quaresma M, Queirós J, Queirós L, Rainho A, da Graça Ramalhinho M, Ramalho P, Raposeira H, Rasteiro F, Rebelo H, Regala FT, Reto D, Ribeiro SB, Rio-Maior H, Rocha R, Rocha RG, Rodrigues L, Román J, Roque S, Rosalino LM, do Rosário IT, Rossa M, Russo D, Sá P, Sabino-Marques H, Salgueiro V, Santos H, Santos J, Santos JPV, Santos N, Santos S, Santos CP, Santos-Reis M, Serronha A, Sierra P, Silva B, Silva CSGM, Silva C, Silva D, da Silva LP, Silva R, Silva C, da Silva Júnior FMR, Sousa P, Sousa-Guedes D, Spadoni G, Tapisso JT, Teixeira D, Teixeira S, Teixeira N, Torres RT, Travassos P, Vale-Gonçalves H, Cidraes-Vieira N, von Merten S, da Luz Mathias M, , MAMMALS IN PORTUGAL: A data set of terrestrial, volant, and marine mammal occurrences in Portugal., Ecology 2022 Jun; 103(6): e3654.
• 2022
  Economos G, Alexandre M, Perceau-Chambard E, Villeneuve L, Subtil F, Haesebaert J, Glehen O, , What is the effectiveness and safety of mirtazapine versus escitalopram in alleviating cancer-associated poly-symptomatology (the MIR-P study)? A mixed-method randomized controlled trial protocol., BMC Palliat Care 2022 May; 21(1): 84.
• 2022
  Mac Kain A, Maarifi G, Aicher SM, Arhel N, Baidaliuk A, Munier S, Donati F, Vallet T, Tran QD, Hardy A, Chazal M, Porrot F, OhAinle M, Carlson-Stevermer J, Oki J, Holden K, Zimmer G, Simon-Lorière E, Bruel T, Schwartz O, van der Werf S, Jouvenet N, Nisole S, Vignuzzi M, Roesch F, Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen., Nat Commun 2022 May; 13(1): 2442.
• 2022
  Benotmane I, Bruel T, Planas D, Fafi-Kremer S, Schwartz O, Caillard S, , A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients., Kidney Int 2022 05; 101(5): 1073-1076.
• 2022
  Molinos-Albert LM, Lorin V, Monceaux V, Orr S, Essat A, Dufloo J, Schwartz O, Rouzioux C, Meyer L, Hocqueloux L, Sáez-Cirión A, Mouquet H, , , Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllers., Nat Commun 2022 Apr; 13(1): 1944.
• 2022
  Simon-Loriere E, Schwartz O, Towards SARS-CoV-2 serotypes?, Nat Rev Microbiol 2022 Apr; 20(4): 187-188.
• 2022
  Prague M, Alexandre M, Thiébaut R, Guedj J, , Within-host models of SARS-CoV-2: What can it teach us on the biological factors driving virus pathogenesis and transmission?, Anaesth Crit Care Pain Med 2022 Apr; 41(2): 101055.
• 2022
  Suliman S, Kjer-Nielsen L, Iwany SK, Lopez Tamara K, Loh L, Grzelak L, Kedzierska K, Ocampo TA, Corbett AJ, McCluskey J, Rossjohn J, León SR, Calderon R, Lecca-Garcia L, Murray MB, Moody DB, Van Rhijn I, , Dual TCR-α Expression on Mucosal-Associated Invariant T Cells as a Potential Confounder of TCR Interpretation., J Immunol 2022 Mar; 208(6): 1389-1395.
• 2022
  Lorin V, Fernández I, Masse-Ranson G, Bouvin-Pley M, Molinos-Albert LM, Planchais C, Hieu T, Péhau-Arnaudet G, Hrebík D, Girelli-Zubani G, Fiquet O, Guivel-Benhassine F, Sanders RW, Walker BD, Schwartz O, Scheid JF, Dimitrov JD, Plevka P, Braibant M, Seaman MS, Bontems F, Di Santo JP, Rey FA, Mouquet H, , Epitope convergence of broadly HIV-1 neutralizing IgA and IgG antibody lineages in a viremic controller., J Exp Med 2022 Mar; 219(3): .
• 2022
  Saunders N, Planas D, Bolland WH, Rodriguez C, Fourati S, Buchrieser J, Planchais C, Prot M, Staropoli I, Guivel-Benhassine F, Porrot F, Veyer D, Péré H, Robillard N, Saliba M, Baidaliuk A, Seve A, Hocqueloux L, Prazuck T, Rey FA, Mouquet H, Simon-Lorière E, Bruel T, Pawlotsky JM, Schwartz O, Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2., EBioMedicine 2022 Mar; 77(): 103934.
• 2022
  Morel A, Imbeaud S, Scemla A, Péré H, Fourgeaud J, Amrouche L, Robillard N, Planas D, Puech J, Simon S, Lanternier F, Bélec L, Zuber J, Schwartz O, Anglicheau D, Chavarot N, Veyer D, , Severe relapse of SARS-CoV-2 infection in a kidney transplant recipient with negative nasopharyngeal SARS-CoV-2 RT-PCR after rituximab., Am J Transplant 2022 Feb; (): .
• 2022
  Henriquez S, Zerbit J, Bruel T, Ouedrani A, Planas D, Deschamps P, Staropoli I, Hadjadj J, Varet B, Ermak N, Bouscary D, Willems L, Fouquet G, Decroocq J, Franchi P, Deau-Fischer B, Terrier B, Tamburini J, Chatenoud L, Schwartz O, Vignon M, , Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma., Blood 2022 02; 139(6): 942-946.
• 2022
  Spencer DA, Goldberg BS, Pandey S, Ordonez T, Dufloo J, Barnette P, Sutton WF, Henderson H, Agnor R, Gao L, Bruel T, Schwartz O, Haigwood NL, Ackerman ME, Hessell AJ, , Phagocytosis by an HIV antibody is associated with reduced viremia irrespective of enhanced complement lysis., Nat Commun 2022 02; 13(1): 662.
• 2022
  Dufloo J, Planchais C, Frémont S, Lorin V, Guivel-Benhassine F, Stefic K, Casartelli N, Echard A, Roingeard P, Mouquet H, Schwartz O, Bruel T, , Broadly neutralizing anti-HIV-1 antibodies tether viral particles at the surface of infected cells., Nat Commun 2022 02; 13(1): 630.
• 2022
  Planas D, Saunders N, Maes P, Guivel-Benhassine F, Planchais C, Buchrieser J, Bolland WH, Porrot F, Staropoli I, Lemoine F, Péré H, Veyer D, Puech J, Rodary J, Baele G, Dellicour S, Raymenants J, Gorissen S, Geenen C, Vanmechelen B, Wawina-Bokalanga T, Martí-Carreras J, Cuypers L, Sève A, Hocqueloux L, Prazuck T, Rey FA, Simon-Loriere E, Bruel T, Mouquet H, André E, Schwartz O, Considerable escape of SARS-CoV-2 Omicron to antibody neutralization., Nature 2022 Feb; 602(7898): 671-675.
• 2022
  Boudhabhay I, Serris A, Servais A, Planas D, Hummel A, Guery B, Parize P, Aguilar C, Dao M, Rouzaud C, Ferriere E, Knebelmann B, Sakhi H, Leruez M, Joly D, Schwartz O, Lanternier F, Bruel T, , COVID-19 outbreak in vaccinated patients from a hemodialysis unit: antibody titers as a marker of protection from infection., Nephrol Dial Transplant 2022 Feb; (): .
• 2022
  Claireaux M, Robinot R, Kervevan J, Patgaonkar M, Staropoli I, Brelot A, Nouël A, Gellenoncourt S, Tang X, Héry M, Volant S, Perthame E, Avettand-Fenoël V, Buchrieser J, Cokelaer T, Bouchier C, Ma L, Boufassa F, Hendou S, Libri V, Hasan M, Zucman D, de Truchis P, Schwartz O, Lambotte O, Chakrabarti LA, , Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry., Nat Commun 2022 Jan; 13(1): 521.
• 2022
  Vila IK, Chamma H, Steer A, Saccas M, Taffoni C, Turtoi E, Reinert LS, Hussain S, Marines J, Jin L, Bonnefont X, Hubert M, Schwartz O, Paludan SR, Van Simaeys G, Doumont G, Sobhian B, Vlachakis D, Turtoi A, Laguette N, , STING orchestrates the crosstalk between polyunsaturated fatty acid metabolism and inflammatory responses., Cell Metab 2022 01; 34(1): 125-139.e8.
• 2022
  Vo HTM, Maestri A, Auerswald H, Sorn S, Lay S, Seng H, Sann S, Ya N, Pean P, Dussart P, Schwartz O, Ly S, Bruel T, Ly S, Duong V, Karlsson EA, Cantaert T, , Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort., Front Immunol 2022 ; 13(): 817905.
• 2022
  Gallais F, Gantner P, Planas D, Solis M, Bruel T, Pierre F, Soulier E, Rossolillo P, Fourati S, Sibilia J, Schwartz O, Fafi-Kremer S, , Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 Vaccine., Front Immunol 2022 ; 13(): 790212.
• 2022
  Corbaux P, Lardy-Cleaud A, Alexandre M, Fontanilles M, Lévy C, Viansone AA, Mailliez A, Debled M, Goncalves A, Le Du F, Lerebours F, Ferrero JM, Eymard JC, Mouret-Reynier MA, Petit T, Frenel JS, Dalenc F, Courtinard C, Chaix M, Bachelot T, , Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancer., Breast Cancer Res Treat 2022 Jan; 191(1): 191-207.
• 2022
  Hasebe D, Alexandre M, Nakamoto T, , Exploration of sensing data to realize intended odor impression using mass spectrum of odor mixture., PLoS One 2022 ; 17(8): e0273011.
• 2021
  Rajah MM, Hubert M, Bishop E, Saunders N, Robinot R, Grzelak L, Planas D, Dufloo J, Gellenoncourt S, Bongers A, Zivaljic M, Planchais C, Guivel-Benhassine F, Porrot F, Mouquet H, Chakrabarti LA, Buchrieser J, Schwartz O, , SARS-CoV-2 Alpha, Beta, and Delta variants display enhanced Spike-mediated syncytia formation., EMBO J 2021 12; 40(24): e108944.
• 2021
  Pelleau S, Woudenberg T, Rosado J, Donnadieu F, Garcia L, Obadia T, Gardais S, Elgharbawy Y, Velay A, Gonzalez M, Nizou JY, Khelil N, Zannis K, Cockram C, Merkling SH, Meola A, Kerneis S, Terrier B, de Seze J, Planas D, Schwartz O, Dejardin F, Petres S, von Platen C, Pellerin SF, Arowas L, de Facci LP, Duffy D, Cheallaigh CN, Dunne J, Conlon N, Townsend L, Duong V, Auerswald H, Pinaud L, Tondeur L, Backovic M, Hoen B, Fontanet A, Mueller I, Fafi-Kremer S, Bruel T, White M, Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection., J Infect Dis 2021 Nov; 224(9): 1489-1499.
• 2021
  Monel B, Planas D, Grzelak L, Smith N, Robillard N, Staropoli I, Goncalves P, Porrot F, Guivel-Benhassine F, Guinet ND, Rodary J, Puech J, Euzen V, Bélec L, Orvoen G, Nunes L, Moulin V, Fourgeaud J, Wack M, Imbeaud S, Campagne P, Duffy D, Santo JPD, Bruel T, Péré H, Veyer D, Schwartz O, , Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study., EBioMedicine 2021 Nov; 73(): 103637.
• 2021
  Goldberg BS, Kaku CI, Dufloo J, Bruel T, Schwartz O, Spencer DA, Hessell AJ, Ackerman ME, , Revisiting an IgG Fc Loss-of-Function Experiment: the Role of Complement in HIV Broadly Neutralizing Antibody b12 Activity., mBio 2021 10; 12(5): e0174321.
• 2021
  Jeronimo CMP, Brito-Sousa JD, Borba MGS, Baía-da-Silva DC, Val FFA, Monteiro WM, Melo GC, Sampaio VS, Alexandre MAA, Xavier M, Bassat Q, Romero GAS, Hajjar LA, Lacerda MVG, , Reply to Nguyen and Frost., Clin Infect Dis 2021 Oct; 73(7): e1775-e1777.
• 2021
  Rajah MM, Bernier A, Buchrieser J, Schwartz O, , The Mechanism and Consequences of SARS-CoV-2 Spike-Mediated Fusion and Syncytia Formation., J Mol Biol 2021 Oct; (): 167280.
• 2021
  Souza MRR, Suzarte JS, Carmo LO, Santos E, Soares LS, Júnior ARV, Santos LGGV, Krause LC, Damasceno FC, Frena M, Alexandre MR, , Assessment of polycyclic aromatic hydrocarbons in three environmental components from a tropical estuary in Northeast Brazil., Mar Pollut Bull 2021 Oct; 171(): 112726.
• 2021
  Meyer B, Chiaravalli J, Gellenoncourt S, Brownridge P, Bryne DP, Daly LA, Grauslys A, Walter M, Agou F, Chakrabarti LA, Craik CS, Eyers CE, Eyers PA, Gambin Y, Jones AR, Sierecki E, Verdin E, Vignuzzi M, Emmott E, , Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential., Nat Commun 2021 09; 12(1): 5553.
• 2021
  Grzelak L, Velay A, Madec Y, Gallais F, Staropoli I, Schmidt-Mutter C, Wendling MJ, Meyer N, Planchais C, Rey D, Mouquet H, Reix N, Glady L, Hansmann Y, Bruel T, De Sèze J, Fontanet A, Gonzalez M, Schwartz O, Fafi-Kremer S, , Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2., J Infect Dis 2021 09; 224(6): 983-988.
• 2021
  Betton M, Livrozet M, Planas D, Fayol A, Monel B, Védie B, Bruel T, Tartour E, Robillard N, Manuguerra JC, Blanchard A, Ghosn J, Visseaux B, Péré H, Lebeaux D, Schwartz O, Veyer D, Hulot JS, , , Sera Neutralizing Activities Against Severe Acute Respiratory Syndrome Coronavirus 2 and Multiple Variants 6 Months After Hospitalization for Coronavirus Disease 2019., Clin Infect Dis 2021 09; 73(6): e1337-e1344.
• 2021
  Smith N, Goncalves P, Charbit B, Grzelak L, Beretta M, Planchais C, Bruel T, Rouilly V, Bondet V, Hadjadj J, Yatim N, Pere H, Merkling SH, Ghozlane A, Kernéis S, Rieux-Laucat F, Terrier B, Schwartz O, Mouquet H, Duffy D, Di Santo JP, , Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection., Nat Immunol 2021 Sep; 22(11):1428-1439.
• 2021
  Marlin R, Godot V, Cardinaud S, Galhaut M, Coleon S, Zurawski S, Dereuddre-Bosquet N, Cavarelli M, Gallouët AS, Maisonnasse P, Dupaty L, Fenwick C, Naninck T, Lemaitre J, Gomez-Pacheco M, Kahlaoui N, Contreras V, Relouzat F, Fang RHT, Wang Z, Ellis J, Chapon C, Centlivre M, Wiedemann A, Lacabaratz C, Surenaud M, Szurgot I, Liljeström P, Planas D, Bruel T, Schwartz O, Werf SV, Pantaleo G, Prague M, Thiébaut R, Zurawski G, Lévy Y, Grand RL, , Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques., Nat Commun 2021 09; 12(1): 5215.
• 2021
  Alexandre M, Prague M, Thiébaut R, , Between-group comparison of area under the curve in clinical trials with censored follow-up: Application to HIV therapeutic vaccines., Stat Methods Med Res 2021 Sep; 30(9): 2130-2147.
• 2021
  Gallais F, Gantner P, Bruel T, Velay A, Planas D, Wendling MJ, Bayer S, Solis M, Laugel E, Reix N, Schneider A, Glady L, Panaget B, Collongues N, Partisani M, Lessinger JM, Fontanet A, Rey D, Hansmann Y, Kling-Pillitteri L, Schwartz O, De Sèze J, Meyer N, Gonzalez M, Schmidt-Mutter C, Fafi-Kremer S, , Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection., EBioMedicine 2021 Sep; 71(): 103561.
• 2021
  Luo X, Mouquet H, Schwartz O, Greene WC, , Bystander CD4 T-cell death is inhibited by broadly neutralizing anti-HIV antibodies only at levels blocking cell-to-cell viral transmission., J Biol Chem 2021 10; 297(4): 101098.
• 2021
  de Cevins C, Luka M, Smith N, Meynier S, Magérus A, Carbone F, García-Paredes V, Barnabei L, Batignes M, Boullé A, Stolzenberg MC, Pérot BP, Charbit B, Fali T, Pirabarakan V, Sorin B, Riller Q, Abdessalem G, Beretta M, Grzelak L, Goncalves P, Di Santo JP, Mouquet H, Schwartz O, Zarhrate M, Parisot M, Bole-Feysot C, Masson C, Cagnard N, Corneau A, Bruneau C, Zhang SY, Casanova JL, Meunier BB, Haroche J, Melki I, Lorrot M, Oualha M, Moulin F, Bonnet D, Belhadjer Z, Leruez M, Allali S, Leguen CG, de Pontual L, , Fischer A, Duffy D, Rieux-Laucat F, Toubiana J, Ménager MM, , A monocyte/dendritic cell molecular signature of SARS-CoV-2 related multisystem inflammatory syndrome in children (MIS-C) with severe myocarditis., Med (N Y) 2021 Aug; (): .
• 2021
  Kernéis S, Planas D, Imbeaud S, Staropoli I, Puech J, Robillard N, Rodary J, Bruel T, Vieillard T, Schwartz O, Belec L, Péré H, Veyer D, , Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated Individual., Open Forum Infect Dis 2021 Aug; 8(8): ofab369.
• 2021
  Yatim N, Boussier J, Tetu P, Smith N, Bruel T, Charbit B, Barnabei L, Corneau A, Da Meda L, Allayous C, Baroudjian B, Jebali M, Herms F, Grzelak L, Staropoli I, Calmettes V, Hadjadj J, Peyrony O, Cassius C, LeGoff J, Kramkimel N, Aractingi S, Fontes M, Blanc C, Rieux-Laucat F, Schwartz O, Terrier B, Duffy D, Lebbé C, , Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection., Sci Adv 2021 08; 7(34): .
• 2021
  Tummino TA, Rezelj VV, Fischer B, Fischer A, O'Meara MJ, Monel B, Vallet T, White KM, Zhang Z, Alon A, Schadt H, O'Donnell HR, Lyu J, Rosales R, McGovern BL, Rathnasinghe R, Jangra S, Schotsaert M, Galarneau JR, Krogan NJ, Urban L, Shokat KM, Kruse AC, García-Sastre A, Schwartz O, Moretti F, Vignuzzi M, Pognan F, Shoichet BK, , Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2., Science 2021 07; 373(6554): 541-547.
• 2021
  Martinat C, Cormier A, Tobaly-Tapiero J, Palmic N, Casartelli N, Mahboubi B, Coggins SA, Buchrieser J, Persaud M, Diaz-Griffero F, Espert L, Bossis G, Lesage P, Schwartz O, Kim B, Margottin-Goguet F, Saïb A, Zamborlini A, , SUMOylation of SAMHD1 at Lysine 595 is required for HIV-1 restriction in non-cycling cells., Nat Commun 2021 07; 12(1): 4582.
• 2021
  Cassius C, Merandet M, Frumholtz L, Bergerat D, Samri A, Grolleau C, Grzelak L, Schwartz O, Yatim N, Moghadam P, Jaume L, Bagot M, Legoff J, Delaugerre C, Bouaziz JD, Le Buanec H, , , Analysis of T cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in chilblain-like lesions patients during the COVID-19 pandemic., Br J Dermatol 2021 Jul; (): .
• 2021
  Gilbert T, Bernard L, Alexandre M, Bin-Dorel S, Villeneuve L, Decullier E, Bonnefoy M, Anc Working Group , , Impact of a Geriatric Intervention to Improve Screening and Management of Undernutrition in Older Patients Undergoing Surgery for Colorectal Cancer: Results of the ANC Stepped-Wedge Trial., Nutrients 2021 Jul; 13(7): .
• 2021
  Planas D, Veyer D, Baidaliuk A, Staropoli I, Guivel-Benhassine F, Rajah MM, Planchais C, Porrot F, Robillard N, Puech J, Prot M, Gallais F, Gantner P, Velay A, Le Guen J, Kassis-Chikhani N, Edriss D, Belec L, Seve A, Courtellemont L, Péré H, Hocqueloux L, Fafi-Kremer S, Prazuck T, Mouquet H, Bruel T, Simon-Lorière E, Rey FA, Schwartz O, , Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization., Nature 2021 08; 596(7871): 276-280.
• 2021
  Buchrieser J, Schwartz O, , Pregnancy complications and Interferon-induced transmembrane proteins (IFITM): balancing antiviral immunity and placental development., C R Biol 2021 Jul; 344(2): 145-156.
• 2021
  Dufloo J, Grzelak L, Staropoli I, Madec Y, Tondeur L, Anna F, Pelleau S, Wiedemann A, Planchais C, Buchrieser J, Robinot R, Ungeheuer MN, Mouquet H, Charneau P, White M, Lévy Y, Hoen B, Fontanet A, Schwartz O, Bruel T, , Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies., Cell Rep Med 2021 05; 2(5): 100275.
• 2021
  Nguyen THO, Koutsakos M, van de Sandt CE, Crawford JC, Loh L, Sant S, Grzelak L, Allen EK, Brahm T, Clemens EB, Auladell M, Hensen L, Wang Z, Nüssing S, Jia X, Günther P, Wheatley AK, Kent SJ, Aban M, Deng YM, Laurie KL, Hurt AC, Gras S, Rossjohn J, Crowe J, Xu J, Jackson D, Brown LE, La Gruta N, Chen W, Doherty PC, Turner SJ, Kotsimbos TC, Thomas PG, Cheng AC, Kedzierska K, , Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patients., Nat Commun 2021 05; 12(1): 2691.
• 2021
  Planas D, Bruel T, Grzelak L, Guivel-Benhassine F, Staropoli I, Porrot F, Planchais C, Buchrieser J, Rajah MM, Bishop E, Albert M, Donati F, Prot M, Behillil S, Enouf V, Maquart M, Smati-Lafarge M, Varon E, Schortgen F, Yahyaoui L, Gonzalez M, De Sèze J, Péré H, Veyer D, Sève A, Simon-Lorière E, Fafi-Kremer S, Stefic K, Mouquet H, Hocqueloux L, van der Werf S, Prazuck T, Schwartz O, Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies., Nat Med 2021 May; 27(5): 917-924.
• 2021
  Arnaud Fontanet, Laura Tondeur, Rebecca Grant, Sarah Temmam, Yoann Madec, Thomas Bigot, Ludivine Grzelak, Isabelle Cailleau, Camille Besombes, Marie-Noëlle Ungeheuer, Charlotte Renaudat, Blanca Liliana Perlaza, Laurence Arowas, Nathalie Jolly, Sandrine Fernandes Pellerin, Lucie Kuhmel, Isabelle Staropoli, Christèle Huon, Kuang-Yu Chen, Bernadette Crescenzo-Chaigne, Sandie Munier, Pierre Charneau, Caroline Demeret, Timothée Bruel, Marc Eloit, Olivier Schwartz, Bruno Hoen, SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020, Eurosurveillance, 2021, 26 (15), pp.2001695. ⟨10.2807/1560-7917.es.2021.26.15.2001695⟩.
• 2021
  Bonsergent E, Grisard E, Buchrieser J, Schwartz O, Théry C, Lavieu G, , Quantitative characterization of extracellular vesicle uptake and content delivery within mammalian cells., Nat Commun 2021 03; 12(1): 1864.
• 2021
  Marot S, Malet I, Leducq V, Zafilaza K, Sterlin D, Planas D, Gothland A, Jary A, Dorgham K, Bruel T, , Burrel S, Boutolleau D, Schwartz O, Gorochov G, Calvez V, Marcelin AG, , Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers., Nat Commun 2021 02; 12(1): 844.
• 2021
  Rosado J, Pelleau S, Cockram C, Merkling SH, Nekkab N, Demeret C, Meola A, Kerneis S, Terrier B, Fafi-Kremer S, de Seze J, Bruel T, Dejardin F, Petres S, Longley R, Fontanet A, Backovic M, Mueller I, White MT, , Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study., Lancet Microbe 2021 Feb; 2(2): e60-e69.
• 2021
  Buchrieser J, Dufloo J, Hubert M, Monel B, Planas D, Rajah MM, Planchais C, Porrot F, Guivel-Benhassine F, Van der Werf S, Casartelli N, Mouquet H, Bruel T, Schwartz O, , Syncytia formation by SARS-CoV-2-infected cells., EMBO J 2021 Feb; 40(3): e107405.
• 2021
  Sterlin D, Mathian A, Miyara M, Mohr A, Anna F, Claër L, Quentric P, Fadlallah J, Devilliers H, Ghillani P, Gunn C, Hockett R, Mudumba S, Guihot A, Luyt CE, Mayaux J, Beurton A, Fourati S, Bruel T, Schwartz O, Lacorte JM, Yssel H, Parizot C, Dorgham K, Charneau P, Amoura Z, Gorochov G, , IgA dominates the early neutralizing antibody response to SARS-CoV-2., Sci Transl Med 2021 01; 13(577): .
• 2021
  Galmiche S, Bruel T, Madec Y, Tondeur L, Grzelak L, Staropoli I, Cailleau I, Ungeheuer MN, Renaudat C, Fernandes Pellerin S, Hoen B, Schwartz O, Fontanet A, , Characteristics Associated with Olfactory and Taste Disorders in COVID-19., Neuroepidemiology 2021 ; 55(5): 381-386.
• 2020
  Buchrieser J, Dufloo J, Hubert M, Monel B, Planas D, Rajah MM, Planchais C, Porrot F, Guivel-Benhassine F, Van der Werf S, Casartelli N, Mouquet H, Bruel T, Schwartz O, , Syncytia formation by SARS-CoV-2-infected cells., EMBO J 2020 12; 39(23): e106267.
• 2020
  Cocozza F, Névo N, Piovesana E, Lahaye X, Buchrieser J, Schwartz O, Manel N, Tkach M, Théry C, Martin-Jaular L, , Extracellular vesicles containing ACE2 efficiently prevent infection by SARS-CoV-2 Spike protein-containing virus., J Extracell Vesicles 2020 12; 10(2): e12050.
• 2020
  Garrido PM, Alexandre MI, Travassos AR, Filipe P, , Dipeptidyl-peptidase IV inhibitor-associated bullous pemphigoid efficiently treated with omalizumab., Dermatol Ther 2020 Nov; 33(6): e14160.
• 2020
  Lorin V, Danckaert A, Porrot F, Schwartz O, Afonso PV, Mouquet H, , Antibody Neutralization of HIV-1 Crossing the Blood-Brain Barrier., mBio 2020 Oct; 11(5): .
• 2020
  Ludivine Grzelak, Sarah Temmam, Cyril Planchais, Caroline Demeret, Laura Tondeur, Christèle Huon, Florence Guivel-Benhassine, Isabelle Staropoli, Maxime Chazal, Jeremy Dufloo, Delphine Planas, Julian Buchrieser, Maaran Michael Rajah, Remy Robinot, Françoise Porrot, Mélanie Albert, Kuang-Yu Chen, Bernadette Crescenzo-Chaigne, Flora Donati, François Anna, Philippe Souque, Marion Gransagne, Jacques Bellalou, Mireille Nowakowski, Marija Backovic, Lila Bouadma, Lucie Le Fevre, Quentin Le Hingrat, Diane Descamps, Annabelle Pourbaix, Cédric Laouénan, Jade Ghosn, Yazdan Yazdanpanah, Camille Besombes, Nathalie Jolly, Sandrine Pellerin-Fernandes, Olivia Cheny, Marie-Noëlle Ungeheuer, Guillaume Mellon, Pascal Morel, Simon Rolland, Felix Rey, Sylvie Behillil, Vincent Enouf, Audrey Lemaitre, Marie-Aude Créach, Stéphane Pêtres, Nicolas Escriou, Pierre Charneau, Arnaud Fontanet, Bruno Hoen, Timothée Bruel, Marc Eloit, Hugo Mouquet, Olivier Schwartz, Sylvie van Der Werf, A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations, Science Translational Medicine, 2020, 12 (559), pp.eabc3103. ⟨10.1126/scitranslmed.abc3103⟩.
• 2020
  Fafi-Kremer S, Bruel T, Madec Y, Grant R, Tondeur L, Grzelak L, Staropoli I, Anna F, Souque P, Fernandes-Pellerin S, Jolly N, Renaudat C, Ungeheuer MN, Schmidt-Mutter C, Collongues N, Bolle A, Velay A, Lefebvre N, Mielcarek M, Meyer N, Rey D, Charneau P, Hoen B, De Seze J, Schwartz O, Fontanet A, , Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France., EBioMedicine 2020 Sep; 59(): 102915.
• 2020
  Buchrieser, J. Dufloo, M. Hubert, B. Monel, D. Planas, M. M. Rajah, C. Planchais, F. Porrot, F. Guivel-Benhassine, S. Van der Werf, N. Casartelli, H. Mouquet, T. Bruel, O. Schwartz, Syncytia formation by SARS-CoV-2 infected cells, bioRxiv.
• 2020
  F. Cocozza, E. Piovesana, N. Névo, X. Lahaye, J. Buchrieser, O. Schwartz, N. Manel, M. Tkach, C. Théry, L. Martin-Jaular, Extracellular vesicles containing ACE2 efficiently prevent infection by SARS-CoV-2 Spike protein-containing virus., bioRxiv, 2020 Jul;.
• 2020
  C. Martinat, A. Cormier, J. Tobaly-Tapiero, N. Palmic, N. Casartelli, S. A. A. Coggins, J. Buchrieser, M. Persaud, F. Diaz-Griffero, L. Espert, G. Bossis, P. Lesage, O. Schwartz, B. Kim, F. Margottin-Goguet, A. Saïb, A. Zamborlini, SUMOylation of SAMHD1 at Lysine 595 is required for HIV-1 restriction in non-cycling cells, bioRxiv.
• 2020
  Lopes JSS, Dos Santos SP, de Almeida LMB, Kayser AP, Reis EFO, de Oliveira KA, do Amaral Queiroz MC, da Silva LP, Marques ABF, da Silva Borges BM, de Almeida AC, , Efficacy of Ultrasound for Localized Fat Treatment on Clinical and Psychological Outcomes: A Randomized, Single-Blind, Placebo-Controlled Clinical Trial., Aesthet Surg J Open Forum 2020 Jun; 2(2): ojaa012.
• 2020
  Blanco-Rodriguez G, Gazi A, Monel B, Frabetti S, Scoca V, Mueller F, Schwartz O, Krijnse-Locker J, Charneau P, Di Nunzio F, , Remodeling of the Core Leads HIV-1 Preintegration Complex into the Nucleus of Human Lymphocytes., J Virol 2020 05; 94(11): .
• 2020
  Mignard C, Maho-Vaillant M, Golinski ML, Balayé P, Prost-Squarcioni C, Houivet E, Calbo SB, Labeille B, Picard-Dahan C, Konstantinou MP, Chaby G, Richard MA, Bouaziz JD, Duvert-Lehembre S, Delaporte E, Bernard P, Caux F, Alexandre M, Ingen-Housz-Oro S, Vabres P, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bédane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Benichou J, Joly P, Hébert V, , , Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy: A Post Hoc Analysis of a Randomized Clinical Trial., JAMA Dermatol 2020 May; 156(5): 545-552.
• 2020
  A. Fontanet, L. Tondeur, Y. Madec, R. Grant, C. Besombes, N. Jolly, S. Fernandes Pellerin, M.-N. Ungeheuer, I. Cailleau, L. Kuhmel, S. Temmam, C. Huon, K.-Y. Chen, B. Crescenzo, S. Munier, C. Demeret, L. Grzelak, I. Staropoli, T. Bruel, P. Gallian, S. Cauchemez, S. van der Werf, O. Schwartz, M. Eloit, B. Hoen, Cluster of COVID-19 in northern France: A retrospective closed cohort study, Cluster of COVID-19 in northern France: A retrospective closed cohort study.
• 2020
  Rajah MM, Monel B, Schwartz O, The entanglement between flaviviruses and ER-shaping proteins, PLoS Pathog. 2020 Apr;16(4):e1008389.
• 2020
  Loh L, Gherardin NA, Sant S, Grzelak L, Crawford JC, Bird NL, Koay HF, van de Sandt CE, Moreira ML, Lappas M, Allen EK, Crowe J, Loudovaris T, Flanagan KL, Quinn KM, Rossjohn J, Thomas PG, Eckle SBG, McCluskey J, Godfrey DI, Kedzierska K, , Human Mucosal-Associated Invariant T Cells in Older Individuals Display Expanded TCRαβ Clonotypes with Potent Antimicrobial Responses., J Immunol 2020 03; 204(5): 1119-1133.
• 2020
  Staropoli I, Dufloo J, Ducher A, Commere PH, Sartori-Rupp A, Novault S, Bruel T, Lorin V, Mouquet H, Schwartz O, Casartelli N, , Flow Cytometry Analysis of HIV-1 Env Conformations at the Surface of Infected Cells and Virions: Role of Nef, CD4, and SERINC5., J Virol 2020 02; 94(6): .
• 2020
  Dufloo J, Guivel-Benhassine F, Buchrieser J, Lorin V, Grzelak L, Dupouy E, Mestrallet G, Bourdic K, Lambotte O, Mouquet H, Bruel T, Schwartz O, , Anti-HIV-1 antibodies trigger non-lytic complement deposition on infected cells., EMBO Rep 2020 02; 21(2): e49351.
• 2020
  Hellert J, Buchrieser J, Larrous F, Minola A, de Melo GD, Soriaga L, England P, Haouz A, Telenti A, Schwartz O, Corti D, Bourhy H, Rey FA, , Structure of the prefusion-locking broadly neutralizing antibody RVC20 bound to the rabies virus glycoprotein., Nat Commun 2020 01; 11(1): 596.
• 2020
  Le Hingrat Q, Visseaux B, Bertine M, Chauveau L, Schwartz O, Collin F, Damond F, Matheron S, Descamps D, Charpentier C, , Genetic variability of Long Terminal Repeat region between HIV-2 groups impacts transcriptional activity, J. Virol. 2020 Jan;.
• 2020
  Labeau A, Simon-Loriere E, Hafirassou ML, Bonnet-Madin L, Tessier S, Zamborlini A, Dupré T, Seta N, Schwartz O, Chaix ML, Delaugerre C, Amara A, Meertens L, A genome-wide CRISPR-Cas9 screen identifies the dolichol-phosphate mannose synthase complex as a host dependency factor for dengue virus infection, J. Virol. 2020 Jan;.
• 2020
  Real-Hohn A, Groznica M, Löffler N, Blaas D, Kowalski H, nanoDSF: In vitro Label-Free Method to Monitor Picornavirus Uncoating and Test Compounds Affecting Particle Stability., Front Microbiol 2020 ; 11(): 1442.
• 2019
  Ruigrok K, Vaney MC, Buchrieser J, Baquero E, Hellert J, Baron B, England P, Schwartz O, Rey FA, Backovic M, , X-ray Structures of the Post-fusion 6-Helix Bundle of the Human Syncytins and their Functional Implications., J Mol Biol 2019 12; 431(24): 4922-4940.
• 2019
  Passos V, Zillinger T, Casartelli N, Wachs AS, Xu S, Malassa A, Steppich K, Schilling H, Franz S, Todt D, Steinmann E, Sutter K, Dittmer U, Bohne J, Schwartz O, Barchet W, Goffinet C, Characterization of Endogenous SERINC5 Protein as Anti-HIV-1 Factor, J. Virol. 2019 Dec;93(24).
• 2019
  Pinto D, Fenwick C, Caillat C, Silacci C, Guseva S, Dehez F, Chipot C, Barbieri S, Minola A, Jarrossay D, Tomaras GD, Shen X, Riva A, Tarkowski M, Schwartz O, Bruel T, Dufloo J, Seaman MS, Montefiori DC, Lanzavecchia A, Corti D, Pantaleo G, Weissenhorn W, Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01, Cell Host Microbe 2019 11;26(5):623-637.e8.
• 2019
  Daher A, Aljayyoussi G, Pereira D, Lacerda MVG, Alexandre MAA, Nascimento CT, Alves JC, da Fonseca LB, da Silva DMD, Pinto DP, Rodrigues DF, Silvino ACR, de Sousa TN, de Brito CFA, Ter Kuile FO, Lalloo DG, , Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine., Malar J 2019 Sep; 18(1): 325.
• 2019
  Buchrieser J, Degrelle SA, Couderc T, Nevers Q, Disson O, Manet C, Donahue DA, Porrot F, Hillion KH, Perthame E, Arroyo MV, Souquere S, Ruigrok K, Dupressoir A, Heidmann T, Montagutelli X, Fournier T, Lecuit M, Schwartz O, , IFITM proteins inhibit placental syncytiotrophoblast formation and promote fetal demise., Science 2019 Jul; 365(6449): 176-180.
• 2019
  Hani L, Chaillon A, Nere ML, Ruffin N, Alameddine J, Salmona M, Lopez Zaragoza JL, Smith DM, Schwartz O, Lelièvre JD, Delaugerre C, Lévy Y, Seddiki N, Proliferative memory SAMHD1low CD4+ T cells harbour high levels of HIV-1 with compartmentalized viral populations, PLoS Pathog. 2019 Jun;15(6):e1007868.
• 2019
  Bruel T, Schwartz O, HIV-1 Envelope FRETted Over by Antibodies, Cell Host Microbe 2019 06;25(6):767-768.
• 2019
  Masse-Ranson G, Dusséaux M, Fiquet O, Darche S, Boussand M, Li Y, Lopez-Lastra S, Legrand N, Corcuff E, Toubert A, Centlivre M, Bruel T, Spits H, Schwartz O, Lévy Y, Strick-Marchand H, Di Santo JP, , Accelerated thymopoiesis and improved T-cell responses in HLA-A2/-DR2 transgenic BRGS-based human immune system mice., Eur J Immunol 2019 06; 49(6): 954-965.
• 2019
  Planchais C, Kök A, Kanyavuz A, Lorin V, Bruel T, Guivel-Benhassine F, Rollenske T, Prigent J, Hieu T, Prazuck T, Lefrou L, Wardemann H, Schwartz O, Dimitrov JD, Hocqueloux L, Mouquet H, HIV-1 Envelope Recognition by Polyreactive and Cross-Reactive Intestinal B Cells, Cell Rep 2019 Apr;27(2):572-585.e7.
• 2019
  Koutsakos M, Illing PT, Nguyen THO, Mifsud NA, Crawford JC, Rizzetto S, Eltahla AA, Clemens EB, Sant S, Chua BY, Wong CY, Allen EK, Teng D, Dash P, Boyd DF, Grzelak L, Zeng W, Hurt AC, Barr I, Rockman S, Jackson DC, Kotsimbos TC, Cheng AC, Richards M, Westall GP, Loudovaris T, Mannering SI, Elliott M, Tangye SG, Wakim LM, Rossjohn J, Vijaykrishna D, Luciani F, Thomas PG, Gras S, Purcell AW, Kedzierska K, , Human CD8+ T cell cross-reactivity across influenza A, B and C viruses., Nat Immunol 2019 05; 20(5): 613-625.
• 2019
  Ramos FN, Mortara SR, Monalisa-Francisco N, Elias JPC, Neto LM, Freitas L, Kersten R, Amorim AM, Matos FB, Nunes-Freitas AF, Alcantara S, Alexandre MHN, de Almeida-Scabbia RJ, de Almeida OJG, Alves FE, de Oliveira Alves RM, Alvim FS, de Andrade ACS, de Andrade S, Aona LYS, Araujo AC, de Araújo KCT, Ariati V, Assis JC, de Azevedo CO, Barbosa BF, Barbosa DEF, Barbosa FDR, de Barros F, Basilio GA, Bataghin FA, Bered F, Bianchi JS, Blum CT, Boelter CR, Bonnet A, Brancalion PHS, Breier TB, Brion CT, Buzatto CR, Cabral A, Cadorin TJ, Caglioni E, Canêz L, Cardoso PH, de Carvalho FS, Carvalho RG, Catharino ELM, Ceballos SJ, Cerezini MT, César RG, Cestari C, Chaves CJN, Citadini-Zanette V, Coelho LFM, Coffani-Nunes JV, Colares R, Colletta GD, Corrêa NM, da Costa AF, da Costa GM, Costa LMS, Costa NGS, Couto DR, Cristofolini C, da Cruz ACR, Del Neri LA, di Pasquo M, Dos Santos Dias A, Dias LDCD, Dislich R, Duarte MC, Fabricante JR, Farache FHA, de Faria APG, Faxina C, Ferreira MTM, Fischer E, Fonseca CR, Fontoura T, Francisco TM, Furtado SG, Galetti M, Garbin ML, de Gasper AL, Goetze M, Gomes-da-Silva J, Gonçalves MFA, Gonzaga DR, Silva ACGE, Guaraldo AC, Guarino ESG, Guislon AV, Hudson LB, Jardim JG, Jungbluth P, Kaeser SDS, Kessous IM, Koch NM, Kuniyoshi YS, Labiak PH, Lapate ME, Santos ACL, Leal RLB, Leite FS, Leitman P, Liboni AP, Liebsch D, Lingner DV, Lombardi JA, Lucas E, Luzzi JDR, Mai P, Mania LF, Mantovani W, Maragni AG, Marques MCM, Marquez G, Martins C, Martins LDN, Martins PLSS, Mazziero FFF, Melo CA, de Melo MMF, Mendes AF, Mesacasa L, Morellato LPC, Moreno VS, Muller A, Murakami MMDS, Cecconello E, Nardy C, Nervo MH, Neves B, Nogueira MGC, Nonato FR, de Oliveira-Filho AT, de Oliveira CPL, Overbeck GE, Marcusso GM, Paciencia MLB, Padilha P, Padilha PT, Pereira ACA, Pereira LC, Pereira RAS, Pincheira-Ulbrich J, Pires JSR, Pizo MA, Pôrto KC, Rattis L, Reis JRM, Reis SGD, da Rocha-Pessôa TC, Rocha CFD, Rocha FS, Rodrigues ARP, Rodrigues RR, Rogalski JM, Rosanelli RL, Rossado A, Rossatto DR, Rother DC, Ruiz-Miranda CR, Saiter FZ, Sampaio MB, Santana LD, Santos JSD, Sartorello R, Sazima M, Schmitt JL, Schneider G, Schroeder BG, Sevegnani L, Júnior VOS, da Silva FR, da Silva MJ, Silva MPP, Silva RG, Silva SM, Singer RB, Siqueira G, Soares LE, de Sousa HC, Spielmann A, Tonetti VR, Toniato MTZ, Ulguim PSB, van den Berg C, van den Berg E, Varassin IG, da Silva IBV, Vibrans AC, Waechter JL, Weissenberg EW, Windisch PG, Wolowski M, Yañez A, Yoshikawa VN, Zandoná LR, Zanella CM, Zanin EM, Zappi DC, Zipparro VB, Zorzanelli JPF, Ribeiro MC, , ATLANTIC EPIPHYTES: a data set of vascular and non-vascular epiphyte plants and lichens from the Atlantic Forest., Ecology 2019 Feb; 100(2): e02541.
• 2019
  Monel B, Rajah MM, Hafirassou ML, Sid Ahmed S, Burlaud-Gaillard J, Zhu PP, Nevers Q, Buchrieser J, Porrot F, Meunier C, Amraoui S, Chazal M, Salles A, Jouvenet N, Roingeard P, Blackstone C, Amara A, Schwartz O, Atlastin Endoplasmic Reticulum-Shaping Proteins Facilitate Zika Virus Replication., J Virol 2019 Dec; 93(23): .
• 2019
  Hébert V, Boulard C, Houivet E, Duvert Lehembre S, Borradori L, Della Torre R, Feliciani C, Fania L, Zambruno G, Camaioni DB, Didona B, Marinovic B, Schmidt E, Schumacher N, Hünefeld C, Schanz S, Kern JS, Hofmann S, Bouyeure AC, Picard-Dahan C, Prost-Squarcioni C, Caux F, Alexandre M, Ingen-Housz-Oro S, Bagot M, Tancrede-Bohin E, Bouaziz JD, Franck N, Vabres P, Labeille B, Richard MA, Delaporte E, Dupuy A, D'Incan M, Quereux G, Skowro F, Paul C, Livideanu CB, Beylot-Barry M, Doutre MS, Avenel-Audran M, Bedane C, Bernard P, Machet L, Maillard H, Jullien D, Debarbieux S, Sassolas B, Misery L, Abasq C, Dereure O, Lagoutte P, Ferranti V, Werth VP, Murrell DF, Hertl M, Benichou J, Joly P, , , , Large International Validation of ABSIS and PDAI Pemphigus Severity Scores., J Invest Dermatol 2019 Jan; 139(1): 31-37.
• 2018
  Parilti R, Caprasse J, Riva R, Alexandre M, Vandegaart H, Bebrone C, Dupont-Gillain C, Howdle SM, Jérôme C, , Antimicrobial peptide encapsulation and sustained release from polymer network particles prepared in supercritical carbon dioxide., J Colloid Interface Sci 2018 Dec; 532(): 112-117.
• 2018
  Colin P, Zhou Z, Staropoli I, Garcia-Perez J, Gasser R, Armani-Tourret M, Benureau Y, Gonzalez N, Jin J, Connell BJ, Raymond S, Delobel P, Izopet J, Lortat-Jacob H, Alcami J, Arenzana-Seisdedos F, Brelot A, Lagane B, CCR5 structural plasticity shapes HIV-1 phenotypic properties, PLoS Pathog. 2018 Dec;14(12):e1007432.
• 2018
  Buchrieser J, Oliva-Martin MJ, Moore MD, Long JCD, Cowley SA, Perez-Simón JA, James W, Venero JL, , RIPK1 is a critical modulator of both tonic and TLR-responsive inflammatory and cell death pathways in human macrophage differentiation., Cell Death Dis 2018 09; 9(10): 973.
• 2018
  Bruel T, Schwartz O, Markers of the HIV-1 reservoir: facts and controversies, Curr Opin HIV AIDS 2018 Sep;13(5):383-388.
• 2018
  Li Y, Masse-Ranson G, Garcia Z, Bruel T, Kök A, Strick-Marchand H, Jouvion G, Serafini N, Lim AI, Dusseaux M, Hieu T, Bourgade F, Toubert A, Finke D, Schwartz O, Bousso P, Mouquet H, Di Santo JP, , A human immune system mouse model with robust lymph node development., Nat Methods 2018 08; 15(8): 623-630.
• 2018
  Dufloo J, Bruel T, Schwartz O, HIV-1 cell-to-cell transmission and broadly neutralizing antibodies, Retrovirology 2018 07;15(1):51.
• 2018
  Sant S, Grzelak L, Wang Z, Pizzolla A, Koutsakos M, Crowe J, Loudovaris T, Mannering SI, Westall GP, Wakim LM, Rossjohn J, Gras S, Richards M, Xu J, Thomas PG, Loh L, Nguyen THO, Kedzierska K, , Single-Cell Approach to Influenza-Specific CD8+ T Cell Receptor Repertoires Across Different Age Groups, Tissues, and Following Influenza Virus Infection., Front Immunol 2018 ; 9(): 1453.
• 2018
  Brelot A, Chakrabarti LA, CCR5 Revisited: How Mechanisms of HIV Entry Govern AIDS Pathogenesis, J. Mol. Biol. 2018 Aug;430(17):2557-2589.
• 2018
  Czuba U, Quintana R, De Pauw-Gillet MC, Bourguignon M, Moreno-Couranjou M, Alexandre M, Detrembleur C, Choquet P, , Atmospheric Plasma Deposition of Methacrylate Layers Containing Catechol/Quinone Groups: An Alternative to Polydopamine Bioconjugation for Biomedical Applications., Adv Healthc Mater 2018 Jun; 7(11): e1701059.
• 2018
  Prigent J, Jarossay A, Planchais C, Eden C, Dufloo J, Kök A, Lorin V, Vratskikh O, Couderc T, Bruel T, Schwartz O, Seaman MS, Ohlenschläger O, Dimitrov JD, Mouquet H, Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers Polyreactivity, Cell Rep 2018 May;23(9):2568-2581.
• 2018
  Dejarnac O, Hafirassou ML, Chazal M, Versapuech M, Gaillard J, Perera-Lecoin M, Umana-Diaz C, Bonnet-Madin L, Carnec X, Tinevez JY, Delaugerre C, Schwartz O, Roingeard P, Jouvenet N, Berlioz-Torrent C, Meertens L, Amara A, , TIM-1 Ubiquitination Mediates Dengue Virus Entry., Cell Rep 2018 05; 23(6): 1779-1793.
• 2018
  Jin J, Momboisse F, Boncompain G, Koensgen F, Zhou Z, Cordeiro N, Arenzana-Seisdedos F, Perez F, Lagane B, Kellenberger E, Brelot A, CCR5 adopts three homodimeric conformations that control cell surface delivery, Sci Signal 2018 05;11(529).
• 2018
  Daher A, Pereira D, Lacerda MVG, Alexandre MAA, Nascimento CT, Alves de Lima E Silva JC, Tada M, Ruffato R, Maia I, Dos Santos TC, Marchesini P, Santelli AC, Lalloo DG, , Efficacy and safety of artemisinin-based combination therapy and chloroquine with concomitant primaquine to treat Plasmodium vivax malaria in Brazil: an open label randomized clinical trial., Malar J 2018 Jan; 17(1): 45.
• 2017
  Shi G, Schwartz O, Compton AA, More than meets the I: the diverse antiviral and cellular functions of interferon-induced transmembrane proteins, Retrovirology 2017 Nov;14(1):53.
• 2017
  Chauveau L, Donahue DA, Monel B, Porrot F, Bruel T, Richard L, Casartelli N, Schwartz O, HIV Fusion in Dendritic Cells Occurs Mainly at the Surface and Is Limited by Low CD4 Levels, J. Virol. 2017 Nov;91(21).
• 2017
  Galvao A, Goncalves D, Alexandre M, Ferreira H, , Mini-laparoscopic hysterectomy for adenocarcinoma in situ of the uterine cervix using interchangeable 5-mm end effectors: a way to cross the line of minimally invasive surgery in gynaecologic oncology., Facts Views Vis Obgyn 2017 Sep; 9(3): 163-166.
• 2017
  Chesarino NM, Compton AA, McMichael TM, Kenney AD, Zhang L, Soewarna V, Davis M, Schwartz O, Yount JS, IFITM3 requires an amphipathic helix for antiviral activity, EMBO Rep. 2017 Aug;.
• 2017
  Morchikh M, Cribier A, Raffel R, Amraoui S, Cau J, Severac D, Dubois E, Schwartz O, Bennasser Y, Benkirane M, HEXIM1 and NEAT1 Long Non-coding RNA Form a Multi-subunit Complex that Regulates DNA-Mediated Innate Immune Response, Mol. Cell 2017 Jul;.
• 2017
  Jellali R, Bertrand V, Alexandre M, Rosière N, Grauwels M, De Pauw-Gillet MC, Jérôme C, , Photoreversibility and Biocompatibility of Polydimethylsiloxane-Coumarin as Adjustable Intraocular Lens Material., Macromol Biosci 2017 Jul; 17(7): .
• 2017
  Monel B, Compton AA, Bruel T, Amraoui S, Burlaud-Gaillard J, Roy N, Guivel-Benhassine F, Porrot F, Génin P, Meertens L, Sinigaglia L, Jouvenet N, Weil R, Casartelli N, Demangel C, Simon-Lorière E, Moris A, Roingeard P, Amara A, Schwartz O, , Zika virus induces massive cytoplasmic vacuolization and paraptosis-like death in infected cells., EMBO J. 2017 06; 36(12): 1653-1668.
• 2017
  Haenseler W, Sansom SN, Buchrieser J, Newey SE, Moore CS, Nicholls FJ, Chintawar S, Schnell C, Antel JP, Allen ND, Cader MZ, Wade-Martins R, James WS, Cowley SA, , A Highly Efficient Human Pluripotent Stem Cell Microglia Model Displays a Neuronal-Co-culture-Specific Expression Profile and Inflammatory Response., Stem Cell Reports 2017 06; 8(6): 1727-1742.
• 2017
  Lorin V, Malbec M, Eden C, Bruel T, Porrot F, Seaman MS, Schwartz O, Mouquet H, Broadly neutralizing antibodies suppress post-transcytosis HIV-1 infectivity, Mucosal Immunol 2017 May;10(3):829.
• 2017
  Passaes CPB, Bruel T, Decalf J, David A, Angin M, Monceaux V, Muller-Trutwin M, Noel N, Bourdic K, Lambotte O, Albert ML, Duffy D, Schwartz O, Sáez-Cirión A, , Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents., J Virol 2017 03; 91(6): .
• 2017
  Descours B, Petitjean G, López-Zaragoza JL, Bruel T, Raffel R, Psomas C, Reynes J, Lacabaratz C, Levy Y, Schwartz O, Lelievre JD, Benkirane M, CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses, Nature 2017 Mar;543(7646):564-567.
• 2017
  Zhivaki D, Lemoine S, Lim A, Morva A, Vidalain PO, Schandene L, Casartelli N, Rameix-Welti MA, Hervé PL, Dériaud E, Beitz B, Ripaux-Lefevre M, Miatello J, Lemercier B, Lorin V, Descamps D, Fix J, Eléouët JF, Riffault S, Schwartz O, Porcheray F, Mascart F, Mouquet H, Zhang X, Tissières P, Lo-Man R, , Respiratory Syncytial Virus Infects Regulatory B Cells in Human Neonates via Chemokine Receptor CX3CR1 and Promotes Lung Disease Severity., Immunity 2017 Feb; 46(2): 301-314.
• 2017
  Buchrieser J, James W, Moore MD, , Human Induced Pluripotent Stem Cell-Derived Macrophages Share Ontogeny with MYB-Independent Tissue-Resident Macrophages., Stem Cell Reports 2017 02; 8(2): 334-345.
• 2017
  Smith N, Pietrancosta N, Davidson S, Dutrieux J, Chauveau L, Cutolo P, Dy M, Scott-Algara D, Manoury B, Zirafi O, McCort-Tranchepain I, Durroux T, Bachelerie F, Schwartz O, Münch J, Wack A, Nisole S, Herbeuval JP, Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement, Nat Commun 2017 02;8:14253.
• 2017
  Compton AA, Schwartz O, They Might Be Giants: Does Syncytium Formation Sink or Spread HIV Infection?, PLoS Pathog. 2017 Feb;13(2):e1006099.
• 2017
  Bruel T, Guivel-Benhassine F, Lorin V, Lortat-Jacob H, Baleux F, Bourdic K, Noël N, Lambotte O, Mouquet H, Schwartz O, Lack of ADCC Breadth of Human Nonneutralizing Anti-HIV-1 Antibodies, J. Virol. 2017 Apr;91(8).
• 2017
  Donahue DA, Porrot F, Couespel N, Schwartz O, SUN2 silencing impairs CD4 T cell proliferation and alters sensitivity to HIV-1 infection independently of Cyclophilin A, J. Virol. 2017 Jan;.
• 2017
  Meertens L, Labeau A, Dejarnac O, Cipriani S, Sinigaglia L, Bonnet-Madin L, Le Charpentier T, Hafirassou ML, Zamborlini A, Cao-Lormeau VM, Coulpier M, Missé D, Jouvenet N, Tabibiazar R, Gressens P, Schwartz O, Amara A, , Axl Mediates ZIKA Virus Entry in Human Glial Cells and Modulates Innate Immune Responses., Cell Rep 2017 01; 18(2): 324-333.
• 2017
  Defize T, Riva R, Thomassin JM, Alexandre M, Herck NV, Prez FD, Jérôme C, , Reversible TAD Chemistry as a Convenient Tool for the Design of (Re)processable PCL-Based Shape-Memory Materials., Macromol Rapid Commun 2017 Jan; 38(1): .
• 2016
  Ariën KK, Baleux F, Desjardins D, Porrot F, Coïc YM, Michiels J, Bouchemal K, Bonnaffé D, Bruel T, Schwartz O, Le Grand R, Vanham G, Dereuddre-Bosquet N, Lortat-Jacob H, CD4-mimetic sulfopeptide conjugates display sub-nanomolar anti-HIV-1 activity and protect macaques against a SHIV162P3 vaginal challenge, Sci Rep 2016 Oct;6:34829.
• 2016
  Bruel T, Mouquet H, Schwartz O, [Antibodies that kill HIV-1-infected cells], Med Sci (Paris) 2016 8-9;32(8-9):671-4.
• 2016
  Compton AA, Roy N, Porrot F, Billet A, Casartelli N, Yount JS, Liang C, Schwartz O, Natural mutations in IFITM3 modulate post-translational regulation and toggle antiviral specificity, EMBO Rep. 2016 Sep;.
• 2016
  Chauveau L, Schwartz O, [A mystery solved: HIV-1 Nef targets SERINC3 and SERINC5], Med Sci (Paris) 2016 Jun-Jul;32(6):560-2.
• 2016
  Coulon PG, Richetta C, Rouers A, Blanchet FP, Urrutia A, Guerbois M, Piguet V, Theodorou I, Bet A, Schwartz O, Tangy F, Graff-Dubois S, Cardinaud S, Moris A, HIV-Infected Dendritic Cells Present Endogenous MHC Class II-Restricted Antigens to HIV-Specific CD4+ T Cells, J. Immunol. 2016 Jul;197(2):517-32.
• 2016
  Lahouassa H, Blondot ML, Chauveau L, Chougui G, Morel M, Leduc M, Guillonneau F, Ramirez BC, Schwartz O, Margottin-Goguet F, HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages, Proc. Natl. Acad. Sci. U.S.A. 2016 Apr;.
• 2016
  Bruel T, Guivel-Benhassine F, Amraoui S, Malbec M, Richard L, Bourdic K, Donahue DA, Lorin V, Casartelli N, Noël N, Lambotte O, Mouquet H, Schwartz O, Elimination of HIV-1-infected cells by broadly neutralizing antibodies, Nat Commun 2016 Mar;7:10844.
• 2016
  Donahue DA, Schwartz O, Actin’ on HIV: How Dendritic Cells Spread Infection, Cell Host Microbe 2016 Mar;19(3):267-9.
• 2016
  Donahue DA, Amraoui S, di Nunzio F, Kieffer C, Porrot F, Opp S, Diaz-Griffero F, Casartelli N, Schwartz O, , SUN2 Overexpression Deforms Nuclear Shape and Inhibits HIV., J Virol 2016 Apr; 90(8): 4199-4214.
• 2016
  Anne Billet, Alex A Compton, Olivier Schwartz, La famille des protéines IFITM : effets antiviraux et fonctions cellulaires, Virologie 2015, 19(6):251-60.
• 2016
  Preeti J, Alexandre M, Pupalan I, Merlin TC, Claudio R, , Chronic Heart Failure and Comorbid Renal Dysfunction – A Focus on Type 2 Cardiorenal Syndrome., Curr Cardiol Rev 2016 ; 12(3): 186-94.
• 2016
  Defteralı Ç, Verdejo R, Majeed S, Boschetti-de-Fierro A, Méndez-Gómez HR, Díaz-Guerra E, Fierro D, Buhr K, Abetz C, Martínez-Murillo R, Vuluga D, Alexandre M, Thomassin JM, Detrembleur C, Jérôme C, Abetz V, López-Manchado MÁ, Vicario-Abejón C, , In Vitro Evaluation of Biocompatibility of Uncoated Thermally Reduced Graphene and Carbon Nanotube-Loaded PVDF Membranes with Adult Neural Stem Cell-Derived Neurons and Glia., Front Bioeng Biotechnol 2016 ; 4(): 94.
• 2015
  Griesbeck M, Ziegler S, Laffont S, Smith N, Chauveau L, Tomezsko P, Sharei A, Kourjian G, Porichis F, Hart M, Palmer CD, Sirignano M, Beisel C, Hildebrandt H, Cénac C, Villani AC, Diefenbach TJ, Le Gall S, Schwartz O, Herbeuval JP, Autran B, Guéry JC, Chang JJ, Altfeld M, Sex Differences in Plasmacytoid Dendritic Cell Levels of IRF5 Drive Higher IFN-α Production in Women, J. Immunol. 2015 Dec;195(11):5327-36.
• 2015
  Carnec X, Meertens L, Dejarnac O, Perera-Lecoin M, Lamine Hafirassou M, Kitaura J, Ramdasi R, Schwartz O, Amara A, The phosphatidylserine and phosphatidylethanolamine receptor CD300a binds dengue virus and enhances infection, J. Virol. 2015 Oct;.
• 2015
  Roesch F, Richard L, Rua R, Porrot F, Casartelli N, Schwartz O, Vpr Enhances Tumor Necrosis Factor Production by HIV-1-Infected T Cells, J. Virol. 2015 Dec;89(23):12118-30.
• 2015
  Joubert PE, Stapleford K, Guivel-Benhassine F, Vignuzzi M, Schwartz O, Albert ML, Inhibition of mTORC1 Enhances the Translation of Chikungunya Proteins via the Activation of the MnK/eIF4E Pathway, PLoS Pathog. 2015 Aug;11(8):e1005091.
• 2015
  Casartelli N, Human Immunodeficiency Virus-1 Cell-To-Cell Transmission And Antiviral Strategies: An Overview, Curr Drug Targets 2015 Aug;.
• 2015
  Ayinde D, Bruel T, Cardinaud S, Porrot F, Prado JG, Moris A, Schwartz O, SAMHD1 Limits HIV-1 Antigen Presentation by Monocyte-Derived Dendritic Cells, J. Virol. 2015 Jul;89(14):6994-7006.
• 2015
  Jochems SP, Jacquelin B, Chauveau L, Huot N, Petitjean G, Lepelley A, Liovat AS, Ploquin MJ, Cartwright EK, Bosinger SE, Silvestri G, Barré-Sinoussi F, Lebon P, Schwartz O, Müller-Trutwin MC, , Plasmacytoid Dendritic Cell Infection and Sensing Capacity during Pathogenic and Nonpathogenic Simian Immunodeficiency Virus Infection., J Virol 2015 Jul; 89(13): 6918-27.
• 2015
  Ruffin N, Brezar V, Ayinde D, Lefebvre C, Schulze Zur Wiesch J, van Lunzen J, Bockhorn M, Schwartz O, Hocini H, Lelievre JD, Banchereau J, Levy Y, Seddiki N, Low SAMHD1 expression following T-cell activation and proliferation renders CD4+ T cells susceptible to HIV-1, AIDS 2015 Mar;29(5):519-30.
• 2015
  Bruni D, Chazal M, Sinigaglia L, Chauveau L, Schwartz O, Desprès P, Jouvenet N, Viral entry route determines how human plasmacytoid dendritic cells produce type I interferons, Sci Signal 2015 Mar;8(366):ra25.
• 2015
  El-Far M, Ancuta P, Routy JP, Zhang Y, Bakeman W, Bordi R, DaFonseca S, Said EA, Gosselin A, Tep TS, Eichbaum Q, van Grevenynghe J, Schwartz O, Freeman GJ, Haddad EK, Chomont N, Sékaly RP, Nef promotes evasion of human immunodeficiency virus type 1-infected cells from the CTLA-4-mediated inhibition of T-cell activation, J. Gen. Virol. 2015 Jun;96(Pt 6):1463-77.
• 2015
  Bruel T, Hamimi C, Dereuddre-Bosquet N, Cosma A, Shin SY, Corneau A, Versmisse P, Karlsson I, Malleret B, Targat B, Barré-Sinoussi F, Le Grand R, Pancino G, Sáez-Cirión A, Vaslin B, Long-term control of simian immunodeficiency virus (SIV) in cynomolgus macaques not associated with efficient SIV-specific CD8+ T-cell responses, J. Virol. 2015 Apr;89(7):3542-56.
• 2015
  Chauveau L, Puigdomenech I, Ayinde D, Roesch F, Porrot F, Bruni D, Visseaux B, Descamps D, Schwartz O, HIV-2 infects resting CD4+ T cells but not monocyte-derived dendritic cells, Retrovirology 2015;12:2.
• 2014
  Compton AA, Bruel T, Porrot F, Mallet A, Sachse M, Euvrard M, Liang C, Casartelli N, Schwartz O, IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread, Cell Host Microbe 2014 Dec;16(6):736-47.
• 2014
  Quillay H, El Costa H, Marlin R, Duriez M, Cannou C, Chrétien F, Fernandez H, Lebreton A, Ighil J, Schwartz O, Barré-Sinoussi F, Nugeyre MT, Menu E, , Distinct characteristics of endometrial and decidual macrophages and regulation of their permissivity to HIV-1 infection by SAMHD1., J Virol 2015 Jan; 89(2): 1329-39.
• 2014
  Siqueira AM, Cavalcante JA, Vítor-Silva S, Reyes-Lecca RC, Alencar AC, Monteiro WM, Alexandre MA, Mourão MP, Guinovart C, Bassat Q, Alecrim Md, Lacerda MV, , Influence of age on the haemoglobin concentration of malaria-infected patients in a reference centre in the Brazilian Amazon., Mem Inst Oswaldo Cruz 2014 Aug; 109(5): 569-76.
• 2014
  Malbec M, Mouquet H, Schwartz O, [HIV-1 cell-to-cell transmission and broadly neutralizing antibodies], Med Sci (Paris) 2014 May;30(5):508-10.
• 2014
  Briolat V, Jouneau L, Carvalho R, Palha N, Langevin C, Herbomel P, Schwartz O, Spaink HP, Levraud JP, Boudinot P, , Contrasted innate responses to two viruses in zebrafish: insights into the ancestral repertoire of vertebrate IFN-stimulated genes., J. Immunol. 2014 May; 192(9): 4328-41.
• 2014
  Zhang X, Casartelli N, Lemoine S, Mozeleski B, Azria E, Le Ray C, Schwartz O, Launay O, Leclerc C, Lo-Man R, Plasmacytoid dendritic cells engagement by influenza vaccine as a surrogate strategy for driving T-helper type 1 responses in human neonatal settings, J. Infect. Dis. 2014 Aug;210(3):424-34.
• 2014
  Bruel T, Dupuy S, Démoulins T, Rogez-Kreuz C, Dutrieux J, Corneau A, Cosma A, Cheynier R, Dereuddre-Bosquet N, Le Grand R, Vaslin B, Plasmacytoid dendritic cell dynamics tune interferon-alfa production in SIV-infected cynomolgus macaques, PLoS Pathog. 2014 Jan;10(1):e1003915.
• 2014
  Nicolas Vabret, Marc Bailly-Bechet, Alice Lepelley, Valérie Najburg, Olivier Schwartz, Bernard Verrier, Frédéric Tangy, Large-Scale Nucleotide Optimization of Simian Immunodeficiency Virus Reduces Its Capacity To Stimulate Type I Interferon In Vitro, Journal of Virology, 2014, 88 (8), pp.1-27. ⟨10.1128/JVI.03223-13⟩.
• 2013
  Malbec M, Porrot F, Rua R, Horwitz J, Klein F, Halper-Stromberg A, Scheid JF, Eden C, Mouquet H, Nussenzweig MC, Schwartz O, Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission, J. Exp. Med. 2013 Dec;210(13):2813-21.
• 2013
  Cruz DJ, Bonotto RM, Gomes RG, da Silva CT, Taniguchi JB, No JH, Lombardot B, Schwartz O, Hansen MA, Freitas-Junior LH, Identification of novel compounds inhibiting chikungunya virus-induced cell death by high throughput screening of a kinase inhibitor library, PLoS Negl Trop Dis 2013;7(10):e2471.
• 2013
  Rey F, Schwartz O, Wain-Hobson S, Gain-of-function research: unknown risks, Science 2013 Oct;342(6156):311.
• 2013
  Palha N, Guivel-Benhassine F, Briolat V, Lutfalla G, Sourisseau M, Ellett F, Wang CH, Lieschke GJ, Herbomel P, Schwartz O, Levraud JP, , Real-time whole-body visualization of Chikungunya Virus infection and host interferon response in zebrafish., PLoS Pathog. 2013 ; 9(9): e1003619.
• 2013
  Roesch F, Schwartz O, The SAMHD1 knockout mouse model: in vivo veritas?, EMBO J. 2013 Sep;32(18):2427-9.
• 2013
  Malbec M, Sourisseau M, Guivel-Benhassine F, Porrot F, Blanchet F, Schwartz O, Casartelli N, HIV-1 Nef promotes the localization of Gag to the cell membrane and facilitates viral cell-to-cell transfer, Retrovirology 2013;10:80.
• 2013
  Zhang X, Lepelley A, Azria E, Lebon P, Roguet G, Schwartz O, Launay O, Leclerc C, Lo-Man R, Neonatal plasmacytoid dendritic cells (pDCs) display subset variation but can elicit potent anti-viral innate responses, PLoS ONE 2013;8(1):e52003.
• 2012
  Puigdomènech I, Casartelli N, Porrot F, Schwartz O, SAMHD1 restricts HIV-1 cell-to-cell transmission and limits immune detection in monocyte-derived dendritic cells, J. Virol. 2013 Mar;87(5):2846-56.
• 2012
  Garcia Z, Lemaître F, van Rooijen N, Albert ML, Levy Y, Schwartz O, Bousso P, Subcapsular sinus macrophages promote NK cell accumulation and activation in response to lymph-borne viral particles, Blood 2012 Dec;120(24):4744-50.
• 2012
  Ayinde D, Casartelli N, Schwartz O, Restricting HIV the SAMHD1 way: through nucleotide starvation, Nat. Rev. Microbiol. 2012 Oct;10(10):675-80.
• 2012
  Joubert PE, Werneke S, de la Calle C, Guivel-Benhassine F, Giodini A, Peduto L, Levine B, Schwartz O, Lenschow D, Albert ML, Chikungunya-induced cell death is limited by ER and oxidative stress-induced autophagy, Autophagy 2012 Aug;8(8):1261-3.
• 2012
  Roesch F, Meziane O, Kula A, Nisole S, Porrot F, Anderson I, Mammano F, Fassati A, Marcello A, Benkirane M, Schwartz O, Hyperthermia stimulates HIV-1 replication, PLoS Pathog. 2012;8(7):e1002792.
• 2012
  Martin-Latil S, Gnädig NF, Mallet A, Desdouits M, Guivel-Benhassine F, Jeannin P, Prevost MC, Schwartz O, Gessain A, Ozden S, Ceccaldi PE, Transcytosis of HTLV-1 across a tight human epithelial barrier and infection of subepithelial dendritic cells, Blood 2012 Jul;120(3):572-80.
• 2012
  Bouyahyaoui Y, Meziane M, Bennani A, Gallouj S, Mikou O, Harmouch T, Amarti A, Mernissi FZ, [Generalized eruptive syringoma], Ann Dermatol Venereol 2012 Jun;139(6-7):508-9.
• 2012
  Joubert PE, Werneke SW, de la Calle C, Guivel-Benhassine F, Giodini A, Peduto L, Levine B, Schwartz O, Lenschow DJ, Albert ML, Chikungunya virus-induced autophagy delays caspase-dependent cell death, J. Exp. Med. 2012 May;209(5):1029-47.
• 2012
  Schilte C, Buckwalter MR, Laird ME, Diamond MS, Schwartz O, Albert ML, Cutting edge: independent roles for IRF-3 and IRF-7 in hematopoietic and nonhematopoietic cells during host response to Chikungunya infection, J. Immunol. 2012 Apr;188(7):2967-71.
• 2012
  Girard-Misguich F, Delgado-Ortega M, Berthon P, Rossignol C, Larcher T, Bruel T, Guibon R, Guillén N, Meurens F, Porcine colon explants in the study of innate immune response to Entamoeba histolytica, Vet. Immunol. Immunopathol. 2012 Feb;145(3-4):611-7.
• 2011
  Girard-Misguich F, Cognie J, Delgado-Ortega M, Berthon P, Rossignol C, Larcher T, Melo S, Bruel T, Guibon R, Chérel Y, Sarradin P, Salmon H, Guillén N, Meurens F, Towards the establishment of a porcine model to study human amebiasis, PLoS ONE 2011;6(12):e28795.
• 2011
  Rua R, Lepelley A, Gessain A, Schwartz O, Innate sensing of foamy viruses by human hematopoietic cells, J. Virol. 2012 Jan;86(2):909-18.
• 2011
  Raquez JM, Vanderstappen S, Meyer F, Verge P, Alexandre M, Thomassin JM, Jérôme C, Dubois P, , Design of cross-linked semicrystalline poly(ε-caprolactone)-based networks with one-way and two-way shape-memory properties through Diels-Alder reactions., Chemistry 2011 Aug; 17(36): 10135-43.
• 2011
  Defize T, Riva R, Raquez JM, Dubois P, Jérôme C, Alexandre M, , Thermoreversibly crosslinked poly(ε-caprolactone) as recyclable shape-memory polymer network., Macromol Rapid Commun 2011 Aug; 32(16): 1264-9.
• 2011
  Genovesio A, Kwon YJ, Windisch MP, Kim NY, Choi SY, Kim HC, Jung S, Mammano F, Perrin V, Boese AS, Casartelli N, Schwartz O, Nehrbass U, Emans N, Automated genome-wide visual profiling of cellular proteins involved in HIV infection, J Biomol Screen 2011 Oct;16(9):945-58.
• 2011
  Buckwalter MR, Nga PT, Gouilh MA, Fiette L, Bureau JF, Laird ME, Buchrieser J, Ozden S, Cheval J, Eloit M, Manuguerra JC, Gessain A, Brey PT, Fontanet A, Albert ML, , Identification of a novel neuropathogenic Theiler’s murine encephalomyelitis virus., J Virol 2011 Jul; 85(14): 6893-905.
• 2011
  Buckwalter MR, Nga PT, Gouilh MA, Fiette L, Bureau JF, Laird ME, Buchrieser J, Ozden S, Cheval J, Eloit M, Manuguerra JC, Gessain A, Brey PT, Fontanet A, Albert ML, Identification of a novel neuropathogenic Theiler’s murine encephalomyelitis virus, J. Virol. 2011 Jul;85(14):6893-905.
• 2011
  Malbec M, Roesch F, Schwartz O, A new role for the HTLV-1 p8 protein: increasing intercellular conduits and viral cell-to-cell transmission, Viruses 2011 Mar;3(3):254-9.
• 2011
  Vuluga D, Thomassin JM, Molenberg I, Huynen I, Gilbert B, Jérôme C, Alexandre M, Detrembleur C, , Straightforward synthesis of conductive graphene/polymer nanocomposites from graphite oxide., Chem Commun (Camb) 2011 Mar; 47(9): 2544-6.
• 2011
  Lepelley A, Louis S, Sourisseau M, Law HK, Pothlichet J, Schilte C, Chaperot L, Plumas J, Randall RE, Si-Tahar M, Mammano F, Albert ML, Schwartz O, Innate sensing of HIV-infected cells, PLoS Pathog. 2011 Feb;7(2):e1001284.
• 2010
  Feldmann J, Schwartz O, HIV-1 Virological Synapse: Live Imaging of Transmission, Viruses 2010 Aug;2(8):1666-80.
• 2010
  Schwartz O, Albert ML, Biology and pathogenesis of chikungunya virus, Nat. Rev. Microbiol. 2010 Jul;8(7):491-500.
• 2010
  Casartelli N, Sourisseau M, Feldmann J, Guivel-Benhassine F, Mallet A, Marcelin AG, Guatelli J, Schwartz O, Tetherin restricts productive HIV-1 cell-to-cell transmission, PLoS Pathog. 2010;6(6):e1000955.
• 2010
  Thomassin JM, Molenberg I, Huynen I, Debuigne A, Alexandre M, Jérôme C, Detrembleur C, , Locating carbon nanotubes (CNTs) at the surface of polymer microspheres using poly(vinyl alcohol) grafted CNTs as dispersion co-stabilizers., Chem Commun (Camb) 2010 May; 46(19): 3330-2.
• 2010
  Floss DM, Mockey M, Zanello G, Brosson D, Diogon M, Frutos R, Bruel T, Rodrigues V, Garzon E, Chevaleyre C, Berri M, Salmon H, Conrad U, Dedieu L, Expression and immunogenicity of the mycobacterial Ag85B/ESAT-6 antigens produced in transgenic plants by elastin-like peptide fusion strategy, J. Biomed. Biotechnol. 2010;2010:274346.
• 2010
  Brandler S, Lepelley A, Desdouits M, Guivel-Benhassine F, Ceccaldi PE, Lévy Y, Schwartz O, Moris A, Preclinical studies of a modified vaccinia virus Ankara-based HIV candidate vaccine: antigen presentation and antiviral effect, J. Virol. 2010 May;84(10):5314-28.
• 2010
  Schilte C, Couderc T, Chretien F, Sourisseau M, Gangneux N, Guivel-Benhassine F, Kraxner A, Tschopp J, Higgs S, Michault A, Arenzana-Seisdedos F, Colonna M, Peduto L, Schwartz O, Lecuit M, Albert ML, , Type I IFN controls chikungunya virus via its action on nonhematopoietic cells., J Exp Med 2010 Feb; 207(2): 429-42.
• 2010
  Bruel T, Guibon R, Melo S, Guillén N, Salmon H, Girard-Misguich F, Meurens F, Epithelial induction of porcine suppressor of cytokine signaling 2 (SOCS2) gene expression in response to Entamoeba histolytica, Dev. Comp. Immunol. 2010 May;34(5):562-71.
• 2009
  Casartelli N, Guivel-Benhassine F, Bouziat R, Brandler S, Schwartz O, Moris A, The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells, J. Exp. Med. 2010 Jan;207(1):39-49.
• 2009
  Nobile C, Rudnicka D, Hasan M, Aulner N, Porrot F, Machu C, Renaud O, Prévost MC, Hivroz C, Schwartz O, Sol-Foulon N, HIV-1 Nef inhibits ruffles, induces filopodia, and modulates migration of infected lymphocytes, J. Virol. 2010 Mar;84(5):2282-93.
• 2009
  Vendrame D, Sourisseau M, Perrin V, Schwartz O, Mammano F, Partial inhibition of human immunodeficiency virus replication by type I interferons: impact of cell-to-cell viral transfer, J. Virol. 2009 Oct;83(20):10527-37.
• 2009
  Rudnicka D, Feldmann J, Porrot F, Wietgrefe S, Guadagnini S, Prévost MC, Estaquier J, Haase AT, Sol-Foulon N, Schwartz O, Simultaneous cell-to-cell transmission of human immunodeficiency virus to multiple targets through polysynapses, J. Virol. 2009 Jun;83(12):6234-46.
• 2009
  Guerbois M, Moris A, Combredet C, Najburg V, Ruffié C, Février M, Cayet N, Brandler S, Schwartz O, Tangy F, Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160DeltaV1V2 is strongly immunogenic, Virology 2009 May;388(1):191-203.
• 2009
  Labruyère C, Monteverde F, Alexandre M, Dubois P, , Exfoliation of clays in poly(dimethylsiloxane) rubber using an unexpected couple: a silicone surfactant and water., J Nanosci Nanotechnol 2009 Apr; 9(4): 2731-8.
• 2008
  Benali S, Peeterbroeck S, Larrieu J, Laffineur F, Pireaux JJ, Alexandre M, Dubois P, , Study of interlayer spacing collapse during polymer/clay nanocomposite melt intercalation., J Nanosci Nanotechnol 2008 Apr; 8(4): 1707-13.
• 2007
  Brandler S, Lucas-Hourani M, Moris A, Frenkiel MP, Combredet C, Février M, Bedouelle H, Schwartz O, Desprès P, Tangy F, Pediatric measles vaccine expressing a dengue antigen induces durable serotype-specific neutralizing antibodies to dengue virus, PLoS Negl Trop Dis 2007;1(3):e96.
• 2007
  Ozden S, Huerre M, Riviere JP, Coffey LL, Afonso PV, Mouly V, de Monredon J, Roger JC, El Amrani M, Yvin JL, Jaffar MC, Frenkiel MP, Sourisseau M, Schwartz O, Butler-Browne G, Desprès P, Gessain A, Ceccaldi PE, Human muscle satellite cells as targets of Chikungunya virus infection, PLoS ONE 2007;2(6):e527.
• 2007
  Sourisseau M, Schilte C, Casartelli N, Trouillet C, Guivel-Benhassine F, Rudnicka D, Sol-Foulon N, Le Roux K, Prevost MC, Fsihi H, Frenkiel MP, Blanchet F, Afonso PV, Ceccaldi PE, Ozden S, Gessain A, Schuffenecker I, Verhasselt B, Zamborlini A, Saïb A, Rey FA, Arenzana-Seisdedos F, Desprès P, Michault A, Albert ML, Schwartz O, Characterization of reemerging chikungunya virus, PLoS Pathog. 2007 Jun;3(6):e89.
• 2007
  Fackler OT, Alcover A, Schwartz O, Modulation of the immunological synapse: a key to HIV-1 pathogenesis?, Nat Rev Immunol. 2007 Apr;7(4):310-7.
• 2007
  Di Bartolo V, Montagne B, Salek M, Jungwirth B, Carrette F, Fourtane J, Sol-Foulon N, Michel F, Schwartz O, Lehmann WD, Acuto O, , A novel pathway down-modulating T cell activation involves HPK-1-dependent recruitment of 14-3-3 proteins on SLP-76., J Exp Med 2007 Mar; 204(3): 681-91.
• 2007
  Sol-Foulon N, Sourisseau M, Porrot F, Thoulouze MI, Trouillet C, Nobile C, Blanchet F, di Bartolo V, Noraz N, Taylor N, Alcover A, Hivroz C, Schwartz O, , ZAP-70 kinase regulates HIV cell-to-cell spread and virological synapse formation., EMBO J. 2007 Jan; 26(2): 516-26.
• 2006
  Sourisseau M, Sol-Foulon N, Porrot F, Blanchet F, Schwartz O, Inefficient human immunodeficiency virus replication in mobile lymphocytes, J. Virol. 2007 Jan;81(2):1000-12.
• 2006
  Ceccaldi PE, Delebecque F, Prevost MC, Moris A, Abastado JP, Gessain A, Schwartz O, Ozden S, DC-SIGN facilitates fusion of dendritic cells with human T-cell leukemia virus type 1-infected cells, J. Virol. 2006 May;80(10):4771-80.
• 2006
  Thoulouze MI, Sol-Foulon N, Blanchet F, Dautry-Varsat A, Schwartz O, Alcover A, Human immunodeficiency virus type-1 infection impairs the formation of the immunological synapse, Immunity 2006 May;24(5):547-61.
• 2006
  Delebecque F, Suspène R, Calattini S, Casartelli N, Saïb A, Froment A, Wain-Hobson S, Gessain A, Vartanian JP, Schwartz O, Restriction of foamy viruses by APOBEC cytidine deaminases, J. Virol. 2006 Jan;80(2):605-14.
• 2005
  Tailleux L, Pham-Thi N, Bergeron-Lafaurie A, Herrmann JL, Charles P, Schwartz O, Scheinmann P, Lagrange PH, de Blic J, Tazi A, Gicquel B, Neyrolles O, DC-SIGN induction in alveolar macrophages defines privileged target host cells for mycobacteria in patients with tuberculosis, PLoS Med. 2005 Dec;2(12):e381.
• 2005
  Mahieux R, Suspène R, Delebecque F, Henry M, Schwartz O, Wain-Hobson S, Vartanian JP, Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases, J. Gen. Virol. 2005 Sep;86(Pt 9):2489-94.
• 2005
  Nobile C, Petit C, Moris A, Skrabal K, Abastado JP, Mammano F, Schwartz O, Covert human immunodeficiency virus replication in dendritic cells and in DC-SIGN-expressing cells promotes long-term transmission to lymphocytes, J. Virol. 2005 May;79(9):5386-99.
• 2004
  Cardinaud S, Moris A, Février M, Rohrlich PS, Weiss L, Langlade-Demoyen P, Lemonnier FA, Schwartz O, Habel A, Identification of cryptic MHC I-restricted epitopes encoded by HIV-1 alternative reading frames, J. Exp. Med. 2004 Apr;199(8):1053-63.
• 2004
  Schwartz O, Cell of the month. Dendritic cell sensing a lymphocyte, Nat. Rev. Mol. Cell Biol. 2004 Mar;5(3):175.
• 2004
  Ploquin MJ, Diop OM, Sol-Foulon N, Mortara L, Faye A, Soares MA, Nerrienet E, Le Grand R, Van Kooyk Y, Amara A, Schwartz O, Barré-Sinoussi F, Müller-Trutwin MC, , DC-SIGN from African green monkeys is expressed in lymph nodes and mediates infection in trans of simian immunodeficiency virus SIVagm., J Virol 2004 Jan; 78(2): 798-810.
• 2003
  Moris A, Nobile C, Buseyne F, Porrot F, Abastado JP, Schwartz O, DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation, Blood 2004 Apr;103(7):2648-54.
• 2003
  Nobile C, Moris A, Porrot F, Sol-Foulon N, Schwartz O, Inhibition of human immunodeficiency virus type 1 Env-mediated fusion by DC-SIGN, J. Virol. 2003 May;77(9):5313-23.
• 2003
  Lozach PY, Lortat-Jacob H, de Lacroix de Lavalette A, Staropoli I, Foung S, Amara A, Houles C, Fieschi F, Schwartz O, Virelizier JL, Arenzana-Seisdedos F, Altmeyer R, DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2, J. Biol. Chem. 2003 May;278(22):20358-66.
• 2002
  Sol-Foulon N, Moris A, Nobile C, Boccaccio C, Engering A, Abastado JP, Heard JM, van Kooyk Y, Schwartz O, HIV-1 Nef-induced upregulation of DC-SIGN in dendritic cells promotes lymphocyte clustering and viral spread, Immunity 2002 Jan;16(1):145-55.
• 1996
  Conio M, Caroli-Bosc F, Maes B, Pugliese V, Demarquay JF, Dumas R, Bellon S, Delmont J, , Early migration of a covered self-expanding metal stent corrected by implantation of a second stent., Am J Gastroenterol 1996 Oct; 91(10): 2212-4.